Upregulation	O
of	O
bcl-2	B-DNA
by	O
the	O
Epstein-Barr	B-protein
virus	I-protein
latent	I-protein
membrane	I-protein
protein	I-protein
LMP1	B-protein
:	O
a	O
B-cell-specific	O
response	O
that	O
is	O
delayed	O
relative	O
to	O
NF-kappa	B-protein
B	I-protein
activation	O
and	O
to	O
induction	O
of	O
cell	B-protein
surface	I-protein
markers	I-protein
.	O

An	O
ability	O
of	O
the	O
Epstein-Barr	B-protein
virus	I-protein
latent	I-protein
membrane	I-protein
protein	I-protein
LMP1	B-protein
to	O
enhance	O
the	O
survival	O
of	O
infected	B-cell_type
B	I-cell_type
cells	I-cell_type
through	O
upregulation	O
of	O
the	O
bcl-2	B-DNA
oncogene	I-DNA
was	O
first	O
suggested	O
by	O
experiments	O
involving	O
gene	O
transfection	O
and	O
the	O
selection	O
of	O
stable	O
LMP1+	B-cell_line
clones	I-cell_line
(	O
S.Henderson	O
,	O
M.	O
Rowe	O
,	O
C.Gregory	O
,	O
F.Wang	O
,	O
E.Kieff	O
,	O
and	O
A.Rickinson	O
,	O
Cell	O
65	O
:	O
1107-1115	O
,	O
1991	O
)	O
.	O

However	O
,	O
it	O
was	O
not	O
possible	O
to	O
ascertain	O
whether	O
Bcl-2	B-protein
upregulation	O
was	O
a	O
specific	O
consequence	O
of	O
LMP1	B-protein
expression	O
or	O
an	O
artifact	O
of	O
the	O
selection	O
procedure	O
whereby	O
rare	O
Bcl-2+	B-cell_line
cells	I-cell_line
already	O
present	O
in	O
the	O
starting	O
population	O
might	O
best	O
be	O
able	O
to	O
tolerate	O
the	O
potentially	O
toxic	O
effects	O
of	O
LMP1	B-protein
.	O

We	O
therefore	O
reexamined	O
this	O
issue	O
by	O
using	O
two	O
different	O
experimental	O
approaches	O
that	O
allowed	O
LMP1	B-protein
-induced	O
effects	O
to	O
be	O
monitored	O
immediately	O
following	O
expression	O
of	O
the	O
viral	O
protein	O
and	O
in	O
the	O
absence	O
of	O
selective	O
pressures	O
;	O
activation	O
of	O
the	O
NF-kappa	B-protein
B	I-protein
transcription	B-protein
factor	I-protein
and	O
upregulation	O
of	O
the	O
cell	B-protein
adhesion	I-protein
molecule	I-protein
ICAM-1	B-protein
were	O
used	O
as	O
early	O
indices	O
of	O
LMP1	B-protein
function	O
.	O

In	O
the	O
first	O
approach	O
,	O
stable	O
clones	O
of	O
two	O
B-cell	B-cell_line
lines	I-cell_line
carrying	O
an	O
LMP1	B-protein
gene	O
under	O
the	O
control	O
of	O
an	O
inducible	O
metallothionein	B-DNA
promoter	I-DNA
were	O
induced	O
to	O
express	O
LMP1	B-protein
in	O
all	O
cells	O
.	O

Activation	O
of	O
NK-kappa	B-protein
B	I-protein
and	O
upregulation	O
of	O
ICAM-1	B-protein
occurred	O
within	O
24	O
h	O
and	O
were	O
followed	O
at	O
48	O
to	O
72	O
h	O
by	O
upregulation	O
of	O
Bcl-2	B-protein
.	O

In	O
the	O
second	O
approach	O
,	O
we	O
tested	O
the	O
generality	O
of	O
this	O
phenomenon	O
by	O
transiently	O
expressing	O
LMP1	B-protein
from	O
a	O
strong	O
constitutively	O
active	O
promoter	O
in	O
a	O
range	O
of	O
different	O
cell	O
types	O
.	O

All	O
six	O
B-cell	B-cell_line
lines	I-cell_line
tested	O
showed	O
NF-kappa	B-protein
B	I-protein
activation	O
in	O
response	O
to	O
LMP1	B-protein
expression	O
,	O
and	O
this	O
was	O
followed	O
in	O
five	O
of	O
six	O
lines	O
by	O
expression	O
of	O
ICAM-1	B-protein
and	O
Bcl-2	B-protein
.	O

In	O
the	O
same	O
experiments	O
,	O
all	O
three	O
non-	O
B-cell	B-cell_line
lines	I-cell_line
showed	O
NF-kappa	B-protein
B	I-protein
activation	O
and	O
ICAM-1	B-protein
upregulation	O
but	O
never	O
any	O
effect	O
upon	O
Bcl-2	B-protein
.	O

We	O
therefore	O
conclude	O
that	O
Bcl-2	B-protein
upregulation	O
is	O
part	O
of	O
the	O
panoply	O
of	O
cellular	O
changes	O
induced	O
by	O
LMP1	B-protein
but	O
that	O
the	O
effect	O
is	O
cell	O
type	O
specific	O
.	O

Our	O
data	O
also	O
suggest	O
that	O
whilst	O
NF-kappa	B-protein
B	I-protein
may	O
be	O
an	O
essential	O
component	O
of	O
LMP1	B-protein
signal	O
transduction	O
,	O
other	O
cell-specific	B-protein
factors	I-protein
may	O
be	O
required	O
to	O
effect	O
some	O
functions	O
of	O
the	O
viral	B-protein
protein	I-protein
.	O

JOURNAL	NULL
OF	NULL
VIROLOGY	NULL
,	NULL
Sept.	NULL
1994	NULL
,	NULL
p.	NULL
5602-5612	NULL
0022-538	NULL
X/94/	NULL
$	NULL
04.00	NULL
+0	NULL
Copyright	NULL
©	NULL
1994	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

68	NULL
,	NULL
No	NULL
.	NULL

9	NULL
Upregulation	NULL
of	NULL
be/-2	NULL
by	NULL
the	NULL
Epstein-Barr	NULL
Virus	NULL
Latent	NULL
Membrane	NULL
Protein	NULL
LMP1	NULL
:	NULL
a	NULL
B-Cell-Specific	NULL
Response	NULL
That	NULL
Is	NULL
Delayed	NULL
Relative	NULL
to	NULL
NF-kB	NULL
Activation	NULL
and	NULL
to	NULL
Induction	NULL
of	NULL
Cell	NULL
Surface	NULL
Markers	NULL
MARTIN	NULL
ROWE	NULL
,	NULL
'*	NULL
MARC	NULL
PENG-PILON	NULL
,	NULL
*	NULL
DAVID	NULL
S.	NULL
HUEN	NULL
,	NULL
'	NULL
ROBERT	NULL
HARDY	NULL
,	NULL
DEBORAH	NULL
CROOM-CARTER	NULL
,	NULL
'	NULL
ERIK	NULL
LUNDGREN	NULL
,	NULL
``	NULL
anp	NULL
ALAN	NULL
B.	NULL
RICKINSON®	NULL
'	NULL
Institute	NULL
of	NULL
Cancer	NULL
Studies	NULL
,	NULL
University	NULL
of	NULL
Birmingham	NULL
Medical	NULL
School	NULL
,	NULL
Birmingham	NULL
B15	NULL
2TJ	NULL
,	NULL
United	NULL
Kingdom	NULL
,	NULL
``	NULL
and	NULL
Department	NULL
of	NULL
Cell	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
University	NULL
of	NULL
Umea	NULL
,	NULL
Umea	NULL
901	NULL
87	NULL
,	NULL
Sweden	NULL
Received	NULL
31	NULL
March	NULL
1994/Accepted	NULL
6	NULL
June	NULL
1994	NULL
An	NULL
ability	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
LMPI	NULL
to	NULL
enhance	NULL
the	NULL
survival	NULL
of	NULL
infected	NULL
B	NULL
cells	NULL
through	NULL
upregulation	NULL
of	NULL
the	NULL
be/-2	NULL
oncogene	NULL
was	NULL
first	NULL
suggested	NULL
by	NULL
experiments	NULL
involving	NULL
gene	NULL
transfection	NULL
and	NULL
the	NULL
selection	NULL
of	NULL
stable	NULL
LMP1*	NULL
clones	NULL
(	NULL
S.	NULL
Henderson	NULL
,	NULL
M.	NULL
Rowe	NULL
,	NULL
C.	NULL
Gregory	NULL
,	NULL
F.	NULL
Wang	NULL
,	NULL
E.	NULL
Kieff	NULL
,	NULL
and	NULL
A.	NULL
Rickinson	NULL
,	NULL
Cell	NULL
65:1107-1115	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
was	NULL
not	NULL
possible	NULL
to	NULL
ascertain	NULL
whether	NULL
Bcel-2	NULL
upregulation	NULL
was	NULL
a	NULL
specific	NULL
consequence	NULL
of	NULL
LMP1	NULL
expression	NULL
or	NULL
an	NULL
artifact	NULL
of	NULL
the	NULL
selection	NULL
procedure	NULL
whereby	NULL
rare	NULL
Bcl-2*	NULL
cells	NULL
already	NULL
present	NULL
in	NULL
the	NULL
starting	NULL
population	NULL
might	NULL
best	NULL
be	NULL
able	NULL
to	NULL
tolerate	NULL
the	NULL
potentially	NULL
toxic	NULL
effects	NULL
of	NULL
LMP1	NULL
.	NULL

We	NULL
therefore	NULL
reexamined	NULL
this	NULL
issue	NULL
by	NULL
using	NULL
two	NULL
different	NULL
experimental	NULL
approaches	NULL
that	NULL
allowed	NULL
LMPI-induced	NULL
effects	NULL
to	NULL
be	NULL
monitored	NULL
immediately	NULL
following	NULL
expression	NULL
of	NULL
the	NULL
viral	NULL
protein	NULL
and	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
selective	NULL
pressures	NULL
;	NULL
activation	NULL
of	NULL
the	NULL
NF-xB	NULL
transcription	NULL
factor	NULL
and	NULL
upregulation	NULL
of	NULL
the	NULL
cell	NULL
adhesion	NULL
molecule	NULL
ICAM-1	NULL
were	NULL
used	NULL
as	NULL
early	NULL
indices	NULL
of	NULL
LMPI1	NULL
function	NULL
.	NULL

In	NULL
the	NULL
first	NULL
approach	NULL
,	NULL
stable	NULL
clones	NULL
of	NULL
two	NULL
B-cell	NULL
lines	NULL
carrying	NULL
an	NULL
LMPI	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
an	NULL
inducible	NULL
metallothionein	NULL
promoter	NULL
were	NULL
induced	NULL
to	NULL
express	NULL
LMP1	NULL
in	NULL
all	NULL
cells	NULL
.	NULL

Activation	NULL
of	NULL
NF-B	NULL
and	NULL
upregulation	NULL
of	NULL
ICAM-1	NULL
occurred	NULL
within	NULL
24	NULL
h	NULL
and	NULL
were	NULL
followed	NULL
at	NULL
48	NULL
to	NULL
72	NULL
h	NULL
by	NULL
upregulation	NULL
of	NULL
Bel-2	NULL
.	NULL

In	NULL
the	NULL
second	NULL
approach	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
generality	NULL
of	NULL
this	NULL
phenomenon	NULL
by	NULL
transiently	NULL
expressing	NULL
LMP1	NULL
from	NULL
a	NULL
strong	NULL
constitutively	NULL
active	NULL
promoter	NULL
in	NULL
a	NULL
range	NULL
of	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

All	NULL
six	NULL
B-cell	NULL
lines	NULL
tested	NULL
showed	NULL
NF-B	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
LMP1	NULL
expression	NULL
,	NULL
and	NULL
this	NULL
was	NULL
followed	NULL
in	NULL
five	NULL
of	NULL
six	NULL
lines	NULL
by	NULL
expression	NULL
of	NULL
ICAM-1	NULL
and	NULL
Bcl-2	NULL
.	NULL

In	NULL
the	NULL
same	NULL
experiments	NULL
,	NULL
all	NULL
three	NULL
non-B-cell	NULL
lines	NULL
showed	NULL
NF-B	NULL
activation	NULL
and	NULL
ICAM-1	NULL
upregulation	NULL
but	NULL
never	NULL
any	NULL
effect	NULL
upon	NULL
Bcl-2	NULL
.	NULL

We	NULL
therefore	NULL
conclude	NULL
that	NULL
Bel-2	NULL
upregulation	NULL
is	NULL
part	NULL
of	NULL
the	NULL
panoply	NULL
of	NULL
cellular	NULL
changes	NULL
induced	NULL
by	NULL
LMP1	NULL
but	NULL
that	NULL
the	NULL
effect	NULL
is	NULL
cell	NULL
type	NULL
specific	NULL
.	NULL

Our	NULL
data	NULL
also	NULL
suggest	NULL
that	NULL
whilst	NULL
may	NULL
be	NULL
an	NULL
essential	NULL
component	NULL
of	NULL
LMP1	NULL
signal	NULL
transduction	NULL
,	NULL
other	NULL
cell-specific	NULL
factors	NULL
may	NULL
be	NULL
required	NULL
to	NULL
effect	NULL
some	NULL
functions	NULL
of	NULL
the	NULL
viral	NULL
protein	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
is	NULL
a	NULL
ubiquitous	NULL
herpesvirus	NULL
in	NULL
humans	NULL
that	NULL
is	NULL
usually	NULL
apathogenic	NULL
but	NULL
which	NULL
is	NULL
also	NULL
associated	NULL
with	NULL
a	NULL
number	NULL
of	NULL
malignant	NULL
diseases	NULL
,	NULL
including	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
(	NULL
BL	NULL
)	NULL
,	NULL
nasopharyngeal	NULL
carcinoma	NULL
,	NULL
and	NULL
Hodgkin	NULL
's	NULL
disease	NULL
(	NULL
37	NULL
,	NULL
57	NULL
)	NULL
.	NULL

In	NULL
healthy	NULL
infected	NULL
individuals	NULL
,	NULL
the	NULL
virus	NULL
persists	NULL
for	NULL
life	NULL
,	NULL
probably	NULL
as	NULL
a	NULL
latent	NULL
infection	NULL
in	NULL
the	NULL
B-lymphoid	NULL
compartment	NULL
(	NULL
14	NULL
,	NULL
56	NULL
)	NULL
.	NULL

Infection	NULL
of	NULL
normal	NULL
B	NULL
lymphocytes	NULL
with	NULL
EBV	NULL
in	NULL
vitro	NULL
results	NULL
in	NULL
growth	NULL
transformation	NULL
and	NULL
the	NULL
establishment	NULL
of	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
(	NULL
LCLs	NULL
)	NULL
with	NULL
infinite	NULL
proliferative	NULL
potential	NULL
.	NULL

This	NULL
growth	NULL
transformation	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
expression	NULL
of	NULL
six	NULL
nuclear	NULL
antigens	NULL
(	NULL
EBNAs	NULL
)	NULL
,	NULL
three	NULL
latent	NULL
membrane	NULL
proteins	NULL
(	NULL
LMPs	NULL
)	NULL
,	NULL
and	NULL
two	NULL
small	NULL
nonpolyadenylated	NULL
RNAs	NULL
(	NULL
EBERs	NULL
)	NULL
that	NULL
are	NULL
constitutively	NULL
expressed	NULL
from	NULL
the	NULL
viral	NULL
genome	NULL
in	NULL
LCLs	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Experiments	NULL
with	NULL
recombinant	NULL
viruses	NULL
have	NULL
demonstrated	NULL
EBNA2	NULL
,	NULL
EBNA3A	NULL
,	NULL
EBNA3C	NULL
,	NULL
and	NULL
LMP1	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
the	NULL
growth	NULL
transformation	NULL
and	NULL
immortalization	NULL
of	NULL
B	NULL
lymphocytes	NULL
(	NULL
6	NULL
,	NULL
19	NULL
,	NULL
24	NULL
,	NULL
51	NULL
)	NULL
.	NULL

Although	NULL
successful	NULL
transformation	NULL
of	NULL
B	NULL
lymphocytes	NULL
by	NULL
EBV	NULL
requires	NULL
the	NULL
coordinate	NULL
expression	NULL
of	NULL
several	NULL
of	NULL
the	NULL
EBV	NULL
latent	NULL
genes	NULL
,	NULL
many	NULL
of	NULL
the	NULL
transformation-associated	NULL
properties	NULL
of	NULL
EBV	NULL
can	NULL
be	NULL
reproduced	NULL
in	NULL
various	NULL
cell	NULL
systems	NULL
by	NULL
expression	NULL
of	NULL
just	NULL
one	NULL
viral	NULL
gene	NULL
which	NULL
encodes	NULL
a	NULL
386-amino-acid	NULL
integral	NULL
membrane	NULL
protein	NULL
,	NULL
LMP1	NULL
.	NULL

This	NULL
protein	NULL
is	NULL
pre-	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Institute	NULL
of	NULL
Cancer	NULL
Studies	NULL
,	NULL
University	NULL
of	NULL
Birmingham	NULL
Medical	NULL
School	NULL
,	NULL
Vincent	NULL
Dr.	NULL
,	NULL
Birmingham	NULL
B15	NULL
2TJ	NULL
,	NULL
United	NULL
Kingdom	NULL
.	NULL

Phone	NULL
:	NULL
21-414	NULL
6876	NULL
.	NULL

Fax	NULL
:	NULL
21-414	NULL
4486	NULL
.	NULL

Electronic	NULL
mailing	NULL
address	NULL
:	NULL
M.Rowe	NULL
@	NULL
BHAM.AC.UK	NULL
.	NULL

5602	NULL
dicted	NULL
to	NULL
have	NULL
a	NULL
short	NULL
hydrophilic	NULL
amino-terminal	NULL
region	NULL
and	NULL
a	NULL
long	NULL
hydrophilic	NULL
carboxy-terminal	NULL
region	NULL
,	NULL
both	NULL
localizing	NULL
to	NULL
the	NULL
cytosolic	NULL
side	NULL
of	NULL
the	NULL
membrane	NULL
,	NULL
and	NULL
six	NULL
membrane-spanning	NULL
hydrophobic	NULL
domains	NULL
(	NULL
12	NULL
,	NULL
28	NULL
,	NULL
32	NULL
)	NULL
.	NULL

The	NULL
biochemical	NULL
properties	NULL
of	NULL
LMP	NULL
I1	NULL
are	NULL
consistent	NULL
with	NULL
it	NULL
being	NULL
a	NULL
growth	NULL
factor	NULL
receptor	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
,	NULL
although	NULL
as	NULL
yet	NULL
there	NULL
is	NULL
no	NULL
evidence	NULL
that	NULL
its	NULL
action	NULL
is	NULL
dependent	NULL
upon	NULL
the	NULL
presence	NULL
of	NULL
any	NULL
ligand	NULL
.	NULL

LMPI1	NULL
has	NULL
the	NULL
properties	NULL
of	NULL
a	NULL
classical	NULL
oncogene	NULL
since	NULL
transfection	NULL
of	NULL
this	NULL
viral	NULL
gene	NULL
into	NULL
immortalized	NULL
,	NULL
but	NULL
nontu-morigenic	NULL
,	NULL
rodent	NULL
fibroblasts	NULL
induces	NULL
a	NULL
fully	NULL
transformed	NULL
phenotype	NULL
which	NULL
enables	NULL
the	NULL
cells	NULL
to	NULL
grow	NULL
as	NULL
tumors	NULL
in	NULL
vivo	NULL
(	NULL
4	NULL
,	NULL
53	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
LMPI1	NULL
in	NULL
human	NULL
epithelial	NULL
cells	NULL
,	NULL
a	NULL
natural	NULL
host	NULL
cell	NULL
type	NULL
for	NULL
EBV	NULL
,	NULL
results	NULL
in	NULL
morphological	NULL
transformation	NULL
and	NULL
inhibition	NULL
of	NULL
normal	NULL
cell	NULL
differentiation	NULL
(	NULL
8	NULL
,	NULL
11	NULL
)	NULL
.	NULL

Transfection	NULL
of	NULL
the	NULL
LMP	NULL
!	NULL

gene	NULL
into	NULL
human	NULL
B	NULL
lymphocytes	NULL
induces	NULL
many	NULL
phenotypic	NULL
changes	NULL
characteristic	NULL
of	NULL
activated	NULL
lymphocytes	NULL
,	NULL
including	NULL
induction	NULL
of	NULL
DNA	NULL
synthesis	NULL
;	NULL
increased	NULL
cell	NULL
size	NULL
;	NULL
upregulation	NULL
of	NULL
various	NULL
cell	NULL
surface	NULL
activation	NULL
markers	NULL
and	NULL
adhesion	NULL
molecules	NULL
,	NULL
e.g	NULL
.	NULL

,	NULL
intercellular	NULL
adhesion	NULL
molecule	NULL
1	NULL
(	NULL
ICAM-1	NULL
)	NULL
and	NULL
leukocyte	NULL
function	NULL
antigen	NULL
3	NULL
(	NULL
LFA-3	NULL
)	NULL
;	NULL
and	NULL
induction	NULL
of	NULL
homotypic	NULL
cell	NULL
adhesion	NULL
(	NULL
39	NULL
,	NULL
54	NULL
,	NULL
55	NULL
)	NULL
.	NULL

While	NULL
most	NULL
studies	NULL
of	NULL
EBV-induced	NULL
transformation	NULL
of	NULL
human	NULL
B	NULL
lymphocytes	NULL
have	NULL
focused	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
an	NULL
activated	NULL
cell	NULL
phenotype	NULL
and	NULL
cell	NULL
proliferation	NULL
,	NULL
there	NULL
is	NULL
another	NULL
property	NULL
of	NULL
EBV	NULL
that	NULL
is	NULL
important	NULL
in	NULL
this	NULL
respect	NULL
.	NULL

Thus	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
full	NULL
complement	NULL
of	NULL
latent	NULL
viral	NULL
genes	NULL
in	NULL
EBV-infected	NULL
B	NULL
cells	NULL
protects	NULL
the	NULL
cells	NULL
from	NULL
death	NULL
by	NULL
programmed	NULL
cell	NULL
death	NULL
,	NULL
or	NULL
apoptosis	NULL
.	NULL

This	NULL
survival	NULL
advantage	NULL
VoL	NULL
.	NULL

68	NULL
,	NULL
1994	NULL
appears	NULL
to	NULL
be	NULL
mediated	NULL
at	NULL
least	NULL
in	NULL
part	NULL
by	NULL
the	NULL
be/-2	NULL
cellular	NULL
oncogene	NULL
,	NULL
which	NULL
encodes	NULL
a	NULL
transmembrane	NULL
protein	NULL
,	NULL
Bcl-2	NULL
,	NULL
that	NULL
inhibits	NULL
apoptosis	NULL
(	NULL
15	NULL
,	NULL
38	NULL
)	NULL
.	NULL

Experiments	NULL
with	NULL
stable	NULL
gene-transfected	NULL
B-lymphoma	NULL
lines	NULL
suggested	NULL
that	NULL
induction	NULL
of	NULL
Bcel-2	NULL
forms	NULL
part	NULL
of	NULL
the	NULL
wide	NULL
panoply	NULL
of	NULL
cellular	NULL
changes	NULL
directly	NULL
induced	NULL
by	NULL
LMP1	NULL
(	NULL
13	NULL
,	NULL
20	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
was	NULL
not	NULL
possible	NULL
to	NULL
exclude	NULL
an	NULL
alternative	NULL
explanation	NULL
;	NULL
that	NULL
the	NULL
observed	NULL
coincidence	NULL
of	NULL
LMP1	NULL
and	NULL
Bcl-2	NULL
expression	NULL
was	NULL
an	NULL
artifact	NULL
of	NULL
the	NULL
clonal	NULL
selection	NULL
procedure	NULL
.	NULL

Thus	NULL
,	NULL
since	NULL
LMP1	NULL
appears	NULL
to	NULL
be	NULL
toxic	NULL
when	NULL
overexpressed	NULL
in	NULL
certain	NULL
cells	NULL
,	NULL
it	NULL
can	NULL
be	NULL
argued	NULL
that	NULL
any	NULL
rare	NULL
Bcl-2*	NULL
cells	NULL
within	NULL
the	NULL
starting	NULL
population	NULL
would	NULL
be	NULL
best	NULL
equipped	NULL
to	NULL
tolerate	NULL
expression	NULL
of	NULL
the	NULL
introduced	NULL
gene	NULL
and	NULL
to	NULL
give	NULL
rise	NULL
to	NULL
a	NULL
stable	NULL
and	NULL
Bcel-2*	NULL
clone	NULL
(	NULL
35	NULL
)	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
argument	NULL
,	NULL
Martin	NULL
et	NULL
al	NULL
.	NULL

(	NULL
35	NULL
)	NULL
noted	NULL
that	NULL
in	NULL
their	NULL
hands	NULL
LMP1	NULL
expression	NULL
did	NULL
not	NULL
cause	NULL
Bci-2	NULL
upregulation	NULL
in	NULL
one	NULL
of	NULL
two	NULL
B-cell	NULL
lines	NULL
tested	NULL
or	NULL
in	NULL
a	NULL
rodent	NULL
fibroblast	NULL
line	NULL
in	NULL
which	NULL
other	NULL
growth-transforming	NULL
properties	NULL
of	NULL
the	NULL
viral	NULL
protein	NULL
were	NULL
well	NULL
documented	NULL
.	NULL

The	NULL
need	NULL
to	NULL
resolve	NULL
these	NULL
issues	NULL
concerning	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
LMP1-Bcl-2	NULL
connection	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
its	NULL
relevance	NULL
to	NULL
other	NULL
cell	NULL
types	NULL
was	NULL
the	NULL
impetus	NULL
for	NULL
the	NULL
present	NULL
work	NULL
.	NULL

Two	NULL
experimental	NULL
approaches	NULL
were	NULL
adopted	NULL
,	NULL
both	NULL
allowing	NULL
the	NULL
effects	NULL
of	NULL
LMP1	NULL
to	NULL
be	NULL
monitored	NULL
in	NULL
cells	NULL
immediately	NULL
following	NULL
expression	NULL
of	NULL
the	NULL
viral	NULL
protein	NULL
and	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
selective	NULL
pressures	NULL
.	NULL

First	NULL
,	NULL
we	NULL
generated	NULL
new	NULL
stable	NULL
clones	NULL
of	NULL
BL	NULL
lines	NULL
carrying	NULL
an	NULL
inducible	NULL
LMP1	NULL
gene	NULL
,	NULL
which	NULL
allowed	NULL
induction	NULL
of	NULL
LMP1	NULL
at	NULL
will	NULL
in	NULL
the	NULL
total	NULL
cell	NULL
population	NULL
within	NULL
hours	NULL
.	NULL

Second	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
expression	NULL
of	NULL
Bcl-2	NULL
at	NULL
the	NULL
single-cell	NULL
level	NULL
in	NULL
a	NULL
range	NULL
of	NULL
B-cell	NULL
and	NULL
non-B-cell	NULL
lines	NULL
in	NULL
which	NULL
transient	NULL
LMP1	NULL
expression	NULL
was	NULL
obtained	NULL
following	NULL
electroporation	NULL
of	NULL
the	NULL
LMP1	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
a	NULL
constitutively	NULL
active	NULL
promoter	NULL
.	NULL

The	NULL
data	NULL
obtained	NULL
reconcile	NULL
the	NULL
results	NULL
of	NULL
Martin	NULL
et	NULL
al	NULL
.	NULL

(	NULL
35	NULL
)	NULL
with	NULL
our	NULL
own	NULL
previous	NULL
observations	NULL
(	NULL
20	NULL
)	NULL
and	NULL
show	NULL
that	NULL
the	NULL
ability	NULL
of	NULL
LMP1	NULL
to	NULL
upregulate	NULL
Bcl-2	NULL
is	NULL
determined	NULL
by	NULL
the	NULL
target	NULL
cell	NULL
type	NULL
.	NULL

A	NULL
role	NULL
for	NULL
LMP1	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
Bcel-2	NULL
emphasizes	NULL
the	NULL
multiplicity	NULL
of	NULL
phenotypic	NULL
effects	NULL
mediated	NULL
by	NULL
this	NULL
viral	NULL
protein	NULL
and	NULL
suggests	NULL
that	NULL
LMP1-activated	NULL
intracellular	NULL
signalling	NULL
pathways	NULL
may	NULL
be	NULL
complex	NULL
.	NULL

In	NULL
this	NULL
context	NULL
,	NULL
it	NULL
is	NULL
of	NULL
interest	NULL
that	NULL
LMP1	NULL
was	NULL
shown	NULL
recently	NULL
to	NULL
induce	NULL
the	NULL
A20	NULL
zinc	NULL
finger	NULL
protein	NULL
,	NULL
which	NULL
affords	NULL
protection	NULL
against	NULL
the	NULL
cytotoxic	NULL
action	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
,	NULL
through	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
26	NULL
)	NULL
.	NULL

This	NULL
transcription	NULL
factor	NULL
was	NULL
also	NULL
previously	NULL
implicated	NULL
in	NULL
the	NULL
LMP1-mediated	NULL
transactivation	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
18	NULL
)	NULL
.	NULL

These	NULL
reports	NULL
prompted	NULL
us	NULL
to	NULL
investigate	NULL
whether	NULL
LMP1	NULL
caused	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
different	NULL
cell	NULL
backgrounds	NULL
and	NULL
whether	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
correlated	NULL
with	NULL
induced	NULL
expression	NULL
of	NULL
ICAM-1	NULL
or	NULL
Bcl-2	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells	NULL
.	NULL

DG75	NULL
,	NULL
BL41	NULL
,	NULL
and	NULL
BJAB	NULL
are	NULL
EBV-negative	NULL
tumor	NULL
lines	NULL
from	NULL
BL	NULL
patients	NULL
(	NULL
47	NULL
)	NULL
.	NULL

RAEL	NULL
,	NULL
ELI-BL	NULL
,	NULL
and	NULL
AKATA	NULL
are	NULL
tumor	NULL
cell	NULL
lines	NULL
from	NULL
EBV-positive	NULL
BL	NULL
patients	NULL
,	NULL
and	NULL
they	NULL
show	NULL
a	NULL
Latency	NULL
I	NULL
form	NULL
of	NULL
infection	NULL
in	NULL
which	NULL
EBNA1	NULL
and	NULL
the	NULL
EBERs	NULL
are	NULL
the	NULL
only	NULL
viral	NULL
genes	NULL
expressed	NULL
(	NULL
36	NULL
,	NULL
46	NULL
,	NULL
48	NULL
)	NULL
.	NULL

Jurkat	NULL
and	NULL
HPB-ALL	NULL
are	NULL
both	NULL
T-cell	NULL
lines	NULL
from	NULL
acute	NULL
lymphocytic	NULL
leukemia	NULL
patients	NULL
(	NULL
5	NULL
)	NULL
,	NULL
and	NULL
K562	NULL
is	NULL
a	NULL
proerythromyelocytic	NULL
cell	NULL
line	NULL
(	NULL
31	NULL
)	NULL
.	NULL

All	NULL
lines	NULL
were	NULL
maintained	NULL
as	NULL
suspension	NULL
cultures	NULL
in	NULL
growth	NULL
medium	NULL
,	NULL
consisting	NULL
of	NULL
bicarbonate-buffered	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
gentamicin	NULL
antibiotic	NULL
,	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
humidified	NULL
atmosphere	NULL
containing	NULL
5	NULL
%	NULL
carbon	NULL
dioxide	NULL
.	NULL

MAbs	NULL
.	NULL

Routine	NULL
detection	NULL
of	NULL
LMP1	NULL
in	NULL
immunofluorescence	NULL
and	NULL
Western	NULL
immunoblotting	NULL
was	NULL
performed	NULL
with	NULL
the	NULL
CS.1-4	NULL
INDUCTION	NULL
OF	NULL
Bcl-2	NULL
BY	NULL
LMP1	NULL
5603	NULL
murine	NULL
immunoglobulin	NULL
G1	NULL
(	NULL
IgG1	NULL
)	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
MAbs	NULL
)	NULL
previously	NULL
described	NULL
(	NULL
45	NULL
)	NULL
.	NULL

In	NULL
certain	NULL
dual-staining	NULL
immunofluorescence	NULL
experiments	NULL
,	NULL
an	NULL
anti-LMP1	NULL
MAb	NULL
,	NULL
LMPO25	NULL
,	NULL
of	NULL
the	NULL
IgG2a	NULL
subclass	NULL
was	NULL
used	NULL
;	NULL
this	NULL
antibody	NULL
was	NULL
produced	NULL
from	NULL
a	NULL
hybridoma	NULL
generated	NULL
by	NULL
fusion	NULL
of	NULL
the	NULL
Sp2/0-Ag14	NULL
myeloma	NULL
with	NULL
spleen	NULL
cells	NULL
immunized	NULL
with	NULL
a	NULL
membrane	NULL
fraction	NULL
of	NULL
Sf9	NULL
cells	NULL
infected	NULL
with	NULL
an	NULL
LMPl-expressing	NULL
recombinant	NULL
baculovirus	NULL
(	NULL
44a	NULL
)	NULL
.	NULL

Bel-2	NULL
protein	NULL
was	NULL
detected	NULL
in	NULL
Western	NULL
blot	NULL
and	NULL
in	NULL
immunofluorescence	NULL
procedures	NULL
with	NULL
a	NULL
murine	NULL
MAb	NULL
,	NULL
bel-2/124	NULL
(	NULL
42	NULL
)	NULL
,	NULL
purchased	NULL
from	NULL
DAKO	NULL
.	NULL

The	NULL
murine	NULL
MAbs	NULL
TS2/9	NULL
(	NULL
49	NULL
)	NULL
and	NULL
RR/1	NULL
(	NULL
44	NULL
)	NULL
were	NULL
employed	NULL
in	NULL
indirect	NULL
immunofluorescence	NULL
assays	NULL
to	NULL
detect	NULL
the	NULL
intercellular	NULL
adhesion	NULL
molecules	NULL
LFA-3	NULL
and	NULL
ICAM-1	NULL
,	NULL
respectively	NULL
.	NULL

A	NULL
fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
-conjugated	NULL
MAb	NULL
to	NULL
ICAM-1	NULL
(	NULL
Immunotech	NULL
)	NULL
was	NULL
used	NULL
in	NULL
certain	NULL
immunofluorescence	NULL
experiments	NULL
in	NULL
which	NULL
dual	NULL
staining	NULL
of	NULL
ICAM-1	NULL
and	NULL
LMP1	NULL
was	NULL
required	NULL
.	NULL

Plasmids	NULL
.	NULL

Two	NULL
types	NULL
of	NULL
LMP1	NULL
expression	NULL
vectors	NULL
were	NULL
used	NULL
,	NULL
one	NULL
containing	NULL
a	NULL
drug	NULL
resistance	NULL
marker	NULL
for	NULL
selection	NULL
of	NULL
stable	NULL
transfectants	NULL
and	NULL
an	NULL
inducible	NULL
human	NULL
metallothionein	NULL
type	NULL
2	NULL
gene	NULL
promoter	NULL
(	NULL
pSV2.gpt.MTLM	NULL
)	NULL
and	NULL
a	NULL
second	NULL
containing	NULL
a	NULL
constitutively	NULL
active	NULL
cytomegalovirus	NULL
(	NULL
CMV	NULL
)	NULL
promoter	NULL
driving	NULL
the	NULL
LMP1	NULL
gene	NULL
(	NULL
pCMVLMP1	NULL
)	NULL
.	NULL

The	NULL
construction	NULL
of	NULL
the	NULL
plasmid	NULL
pSV2.gpt.MTLM	NULL
and	NULL
the	NULL
pSV2.gpt	NULL
control	NULL
vector	NULL
have	NULL
previously	NULL
been	NULL
described	NULL
(	NULL
53	NULL
)	NULL
,	NULL
as	NULL
have	NULL
the	NULL
pCMVLMP1	NULL
plasmid	NULL
and	NULL
its	NULL
vector	NULL
control	NULL
construct	NULL
,	NULL
pCMVLMPA	NULL
(	NULL
39	NULL
)	NULL
.	NULL

The	NULL
«	NULL
kB.CONA.LUC	NULL
reporter	NULL
plasmid	NULL
(	NULL
3	NULL
)	NULL
contains	NULL
three	NULL
NF-	NULL
«	NULL
B	NULL
enhancer	NULL
elements	NULL
upstream	NULL
of	NULL
a	NULL
conalbumin	NULL
promoter	NULL
driving	NULL
a	NULL
luciferase	NULL
gene	NULL
.	NULL

The	NULL
pCMV.LTR.GH	NULL
plasmid	NULL
was	NULL
constructed	NULL
by	NULL
J	NULL
.	NULL

Sample	NULL
(	NULL
Department	NULL
of	NULL
Virology	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
St.	NULL
Jude	NULL
Children	NULL
's	NULL
Research	NULL
Hospital	NULL
,	NULL
Memphis	NULL
,	NULL
Tenn.	NULL
)	NULL
and	NULL
contains	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
coupled	NULL
to	NULL
the	NULL
CMV	NULL
IE	NULL
promoter	NULL
in	NULL
front	NULL
of	NULL
the	NULL
human	NULL
growth	NULL
hormone	NULL
gene	NULL
.	NULL

Electroporation	NULL
.	NULL

Transfection	NULL
of	NULL
DNA	NULL
into	NULL
cell	NULL
lines	NULL
was	NULL
performed	NULL
by	NULL
electroporating	NULL
10	NULL
``	NULL
cells	NULL
in	NULL
500	NULL
pl	NULL
of	NULL
growth	NULL
medium	NULL
in	NULL
4-mm-gap	NULL
cuvettes	NULL
with	NULL
a	NULL
Bio-Rad	NULL
Gene	NULL
Pulser	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
gently	NULL
mixed	NULL
with	NULL
10	NULL
pg	NULL
of	NULL
DNA	NULL
and	NULL
allowed	NULL
to	NULL
stand	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
5	NULL
min	NULL
before	NULL
electroporation	NULL
at	NULL
960	NULL
wF	NULL
and	NULL
at	NULL
predetermined	NULL
optimum	NULL
voltages	NULL
for	NULL
each	NULL
cell	NULL
line	NULL
(	NULL
380	NULL
V	NULL
for	NULL
K562	NULL
;	NULL
340	NULL
V	NULL
for	NULL
HPB-ALL	NULL
;	NULL
320	NULL
V	NULL
for	NULL
BJAB	NULL
and	NULL
BL41	NULL
;	NULL
310	NULL
V	NULL
for	NULL
Jurkat	NULL
;	NULL
300V	NULL
for	NULL
DG75	NULL
,	NULL
ELI-BL	NULL
,	NULL
and	NULL
AKATA	NULL
;	NULL
260V	NULL
for	NULL
RAEL	NULL
)	NULL
.	NULL

After	NULL
electroporation	NULL
,	NULL
cells	NULL
were	NULL
allowed	NULL
to	NULL
stand	NULL
for	NULL
5	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
before	NULL
transfer	NULL
to	NULL
prewarmed	NULL
growth	NULL
medium	NULL
.	NULL

Production	NULL
of	NULL
stable	NULL
transfectants	NULL
with	NULL
inducible	NULL
LMPI	NULL
expression	NULL
.	NULL

The	NULL
BL41	NULL
series	NULL
of	NULL
stable	NULL
transfectants	NULL
(	NULL
BL41-gpt	NULL
and	NULL
BL41-MTLM	NULL
)	NULL
were	NULL
generated	NULL
previously	NULL
with	NULL
the	NULL
pSV2.gpt	NULL
and	NULL
pSV2.gpt.MTLM	NULL
plasmids	NULL
and	NULL
have	NULL
been	NULL
described	NULL
elsewhere	NULL
(	NULL
55	NULL
)	NULL
.	NULL

The	NULL
ELI-BL	NULL
series	NULL
of	NULL
stable	NULL
transfectants	NULL
(	NULL
ELI-gpt	NULL
and	NULL
ELI-MTLM	NULL
)	NULL
were	NULL
generated	NULL
in	NULL
the	NULL
present	NULL
study	NULL
with	NULL
the	NULL
same	NULL
vectors	NULL
and	NULL
were	NULL
obtained	NULL
by	NULL
electroporating	NULL
10	NULL
``	NULL
ELI-BL	NULL
cells	NULL
,	NULL
which	NULL
were	NULL
then	NULL
incubated	NULL
overnight	NULL
as	NULL
a	NULL
bulk	NULL
culture	NULL
in	NULL
10	NULL
ml	NULL
of	NULL
growth	NULL
medium	NULL
before	NULL
addition	NULL
of	NULL
mycophenolic	NULL
acid	NULL
(	NULL
0.2	NULL
pg/ml	NULL
)	NULL
,	NULL
xanthine	NULL
(	NULL
160	NULL
pg/ml	NULL
)	NULL
,	NULL
and	NULL
hypoxanthine	NULL
(	NULL
10	NULL
pg/ml	NULL
)	NULL
and	NULL
seeding	NULL
into	NULL
188	NULL
culture	NULL
wells	NULL
of	NULL
two	NULL
96-microwell	NULL
tissue	NULL
culture	NULL
plates	NULL
.	NULL

Drug-resistant	NULL
colonies	NULL
were	NULL
screened	NULL
for	NULL
LMP1	NULL
expression	NULL
by	NULL
Western	NULL
blot	NULL
at	NULL
10	NULL
to	NULL
20	NULL
days	NULL
after	NULL
transfection	NULL
.	NULL

Lines	NULL
which	NULL
showed	NULL
efficient	NULL
induction	NULL
of	NULL
LMP1	NULL
expression	NULL
by	NULL
heavy	NULL
metals	NULL
were	NULL
identified	NULL
by	NULL
being	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
6	NULL
M	NULL
cadmium	NULL
chloride	NULL
or	NULL
75	NULL
wM	NULL
zinc	NULL
chloride	NULL
for	NULL
24	NULL
h.	NULL
Subsequent	NULL
induction	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
6	NULL
uM	NULL
cadmium	NULL
chloride	NULL
since	NULL
this	NULL
showed	NULL
limited	NULL
toxicity	NULL
compared	NULL
with	NULL
zinc	NULL
chloride	NULL
in	NULL
longer-term	NULL
cultures	NULL
.	NULL

Electroporation	NULL
and	NULL
transient	NULL
expression	NULL
of	NULL
transfected	NULL
genes	NULL
.	NULL

pCMVLMP1	NULL
or	NULL
the	NULL
vector	NULL
control	NULL
plasmid	NULL
,	NULL
pCMV-	NULL
5604	NULL
ROWE	NULL
ET	NULL
AL	NULL
.	NULL

LMPA	NULL
,	NULL
was	NULL
electroporated	NULL
into	NULL
various	NULL
cell	NULL
lines	NULL
at	NULL
the	NULL
optimum	NULL
voltages	NULL
for	NULL
each	NULL
line	NULL
(	NULL
see	NULL
above	NULL
)	NULL
.	NULL

The	NULL
transfected	NULL
cells	NULL
were	NULL
transferred	NULL
to	NULL
10	NULL
ml	NULL
of	NULL
prewarmed	NULL
growth	NULL
medium	NULL
and	NULL
cultured	NULL
for	NULL
1	NULL
to	NULL
3	NULL
days	NULL
at	NULL
37°C	NULL
for	NULL
analysis	NULL
of	NULL
LMPI	NULL
gene	NULL
expression	NULL
and	NULL
cellular	NULL
phenotype	NULL
.	NULL

The	NULL
number	NULL
of	NULL
viable	NULL
cells	NULL
at	NULL
24	NULL
h	NULL
postelectroporation	NULL
was	NULL
typically	NULL
about	NULL
2	NULL
x	NULL
10°	NULL
to	NULL
4	NULL
x	NULL
10°	NULL
cells	NULL
,	NULL
with	NULL
some	NULL
lines	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
DG75	NULL
,	NULL
HPB-ALL	NULL
,	NULL
and	NULL
K562	NULL
)	NULL
consistently	NULL
showing	NULL
greater	NULL
tolerance	NULL
of	NULL
the	NULL
electroporation	NULL
than	NULL
other	NULL
lines	NULL
.	NULL

Samples	NULL
of	NULL
electroporated	NULL
cells	NULL
that	NULL
were	NULL
to	NULL
be	NULL
analyzed	NULL
by	NULL
immunofluorescence	NULL
were	NULL
first	NULL
depleted	NULL
of	NULL
dead	NULL
cells	NULL
and	NULL
debris	NULL
by	NULL
centrifugation	NULL
over	NULL
a	NULL
discontinuous	NULL
gradient	NULL
of	NULL
Lymphoprep	NULL
(	NULL
Nycomed	NULL
AS	NULL
,	NULL
Oslo	NULL
,	NULL
Norway	NULL
)	NULL
.	NULL

Indirect	NULL
immunofluorescence	NULL
analysis	NULL
of	NULL
cell	NULL
surface	NULL
phenotype	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
,	NULL
washed	NULL
once	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
containing	NULL
10	NULL
%	NULL
normal	NULL
goat	NULL
serum	NULL
(	NULL
PBS-ngs	NULL
)	NULL
,	NULL
and	NULL
divided	NULL
into	NULL
aliquots	NULL
of	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
to	NULL
be	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
at	NULL
0°C	NULL
with	NULL
50	NULL
pl	NULL
of	NULL
MAb	NULL
diluted	NULL
to	NULL
10	NULL
pg/ml	NULL
in	NULL
PBS-ngs	NULL
.	NULL

Following	NULL
two	NULL
washes	NULL
with	NULL
PBS	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
at	NULL
0°C	NULL
with	NULL
50	NULL
wl	NULL
of	NULL
FITC-conjugated	NULL
goat	NULL
anti-mouse	NULL
IgG	NULL
{	NULL
(	NULL
FO257	NULL
;	NULL
Sigma	NULL
)	NULL
diluted	NULL
1:50	NULL
in	NULL
PBS-ngs	NULL
plus	NULL
10	NULL
%	NULL
normal	NULL
human	NULL
serum	NULL
(	NULL
PBS-ngs-nhs	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
washed	NULL
twice	NULL
in	NULL
PBS	NULL
and	NULL
fixed	NULL
at	NULL
4°C	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
1	NULL
%	NULL
paraformaldehyde	NULL
in	NULL
PBS	NULL
.	NULL

Fluorescence	NULL
staining	NULL
of	NULL
cell	NULL
surface	NULL
markers	NULL
was	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
with	NULL
a	NULL
Becton-Dickinson	NULL
Flow	NULL
440	NULL
set	NULL
to	NULL
measure	NULL
FITC	NULL
emission	NULL
on	NULL
a	NULL
linear	NULL
immunofluorescence	NULL
intensity	NULL
scale	NULL
.	NULL

Western	NULL
blotting	NULL
for	NULL
LMPI	NULL
and	NULL
Bcl-2	NULL
expression	NULL
.	NULL

Cells	NULL
were	NULL
solubilized	NULL
and	NULL
separated	NULL
by	NULL
Laemmli	NULL
discontinuous	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
before	NULL
being	NULL
clectroblotted	NULL
onto	NULL
nitrocellulose	NULL
filters	NULL
for	NULL
probing	NULL
with	NULL
CS.1-4	NULL
(	NULL
anti-LMP1	NULL
)	NULL
or	NULL
bel-2/124	NULL
(	NULL
anti-Bel-2	NULL
)	NULL
MAb	NULL
and	NULL
detection	NULL
with	NULL
'*°I-protein	NULL
A	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Immunofluorescence	NULL
on	NULL
fixed-cell	NULL
smears	NULL
.	NULL

At	NULL
18	NULL
,	NULL
48	NULL
,	NULL
or	NULL
72	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
viable	NULL
cells	NULL
were	NULL
recovered	NULL
by	NULL
centrifugation	NULL
over	NULL
a	NULL
Lymphoprep	NULL
gradient	NULL
,	NULL
washed	NULL
in	NULL
PBS	NULL
,	NULL
and	NULL
resuspended	NULL
at	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
in	NULL
PBS	NULL
.	NULL

This	NULL
suspension	NULL
was	NULL
used	NULL
to	NULL
prepare	NULL
cell	NULL
smears	NULL
on	NULL
microscope	NULL
slides	NULL
which	NULL
were	NULL
air	NULL
dried	NULL
and	NULL
then	NULL
fixed	NULL
in	NULL
acetone-methanol	NULL
(	NULL
1:1	NULL
)	NULL
at	NULL
-20°C	NULL
for	NULL
5	NULL
min	NULL
.	NULL

The	NULL
smears	NULL
were	NULL
rehydrated	NULL
in	NULL
PBS-ngs-nhs	NULL
)	NULL
.	NULL

For	NULL
the	NULL
detection	NULL
of	NULL
LMP1	NULL
and	NULL
Bel-2	NULL
,	NULL
the	NULL
smears	NULL
were	NULL
incubated	NULL
for	NULL
2	NULL
h	NULL
at	NULL
37°C	NULL
with	NULL
MAbs	NULL
to	NULL
LMP	NULL
I	NULL
(	NULL
CS.1-4	NULL
)	NULL
or	NULL
to	NULL
Bel-2	NULL
(	NULL
bel-2/124	NULL
)	NULL
,	NULL
diluted	NULL
1:5	NULL
in	NULL
PBS-ngs-nhs	NULL
.	NULL

After	NULL
three	NULL
washes	NULL
of	NULL
5	NULL
min	NULL
each	NULL
in	NULL
PBS	NULL
,	NULL
the	NULL
smears	NULL
were	NULL
reacted	NULL
for	NULL
1	NULL
h	NULL
with	NULL
FITC-conjugated	NULL
goat	NULL
antibodies	NULL
to	NULL
mouse	NULL
IgG1	NULL
(	NULL
Southern	NULL
Biotechnology	NULL
As-sociates	NULL
)	NULL
diluted	NULL
in	NULL
PBS-ngs-nhs	NULL
.	NULL

Detection	NULL
of	NULL
ICAM-1	NULL
was	NULL
achieved	NULL
by	NULL
incubating	NULL
the	NULL
rehydrated	NULL
smears	NULL
for	NULL
1	NULL
h	NULL
with	NULL
FITC-conjugated	NULL
MAb	NULL
to	NULL
ICAM-1	NULL
(	NULL
Immunotech	NULL
)	NULL
diluted	NULL
1:25	NULL
in	NULL
PBS-ngs-nhs	NULL
.	NULL

Following	NULL
FITC	NULL
labelling	NULL
of	NULL
LMP1	NULL
,	NULL
Bel-2	NULL
,	NULL
or	NULL
ICAM-1	NULL
as	NULL
described	NULL
above	NULL
,	NULL
the	NULL
smears	NULL
were	NULL
washed	NULL
once	NULL
in	NULL
PBS	NULL
,	NULL
then	NULL
incubated	NULL
with	NULL
propidium	NULL
iodide	NULL
(	NULL
10	NULL
pg/ml	NULL
)	NULL
to	NULL
counterstain	NULL
the	NULL
nuclei	NULL
,	NULL
and	NULL
washed	NULL
a	NULL
further	NULL
three	NULL
times	NULL
in	NULL
PBS	NULL
before	NULL
being	NULL
mounted	NULL
in	NULL
DABCO	NULL
(	NULL
1,4-diazobicyclo-	NULL
[	NULL
2,2,2	NULL
]	NULL
-octane	NULL
)	NULL
antifading	NULL
mountant	NULL
(	NULL
23	NULL
)	NULL
for	NULL
analysis	NULL
by	NULL
confocal	NULL
microscopy	NULL
.	NULL

Dual	NULL
staining	NULL
for	NULL
ICAM-	NULL
!	NULL

and	NULL
LMPI	NULL
was	NULL
performed	NULL
by	NULL
first	NULL
staining	NULL
the	NULL
smears	NULL
with	NULL
FITC-anti-ICAM-1	NULL
as	NULL
described	NULL
above	NULL
and	NULL
then	NULL
incubating	NULL
them	NULL
with	NULL
LMPO25	NULL
(	NULL
an	NULL
1gG2a	NULL
subclass	NULL
anti-LMP1	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
Texas	NULL
Red-conjugated	NULL
goat	NULL
anti-mouse	NULL
IgG2a	NULL
reagent	NULL
(	NULL
Southern	NULL
Biotechnology	NULL
Associates	NULL
)	NULL
.	NULL

Dual	NULL
staining	NULL
for	NULL
Bel-2	NULL
and	NULL
LMP1	NULL
was	NULL
performed	NULL
by	NULL
first	NULL
staining	NULL
the	NULL
smears	NULL
with	NULL
bel-2/124	NULL
followed	NULL
by	NULL
FITC-anti-mouse	NULL
IgGl	NULL
as	NULL
described	NULL
above	NULL
and	NULL
then	NULL
staining	NULL
for	NULL
LMP	NULL
I	NULL
with	NULL
LMPO25	NULL
followed	NULL
by	NULL
a	NULL
Texas	NULL
Red-conjugated	NULL
goat	NULL
anti-mouse	NULL
IgG2a	NULL
.	NULL

Confocal	NULL
microscopy	NULL
was	NULL
performed	NULL
with	NULL
a	NULL
Molecular	NULL
Dynamics	NULL
system	NULL
;	NULL
the	NULL
micrographs	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
and	NULL
5	NULL
are	NULL
look-through	NULL
projections	NULL
of	NULL
30	NULL
to	NULL
40	NULL
scanned	NULL
J.	NULL
ViroL	NULL
.	NULL

sections	NULL
with	NULL
voxel	NULL
sizes	NULL
of	NULL
0.07	NULL
pum	NULL
(	NULL
width	NULL
)	NULL
by	NULL
0.07	NULL
wm	NULL
(	NULL
length	NULL
)	NULL
by	NULL
0.3	NULL
um	NULL
(	NULL
depth	NULL
)	NULL
and	NULL
with	NULL
amplifiers	NULL
set	NULL
to	NULL
exploit	NULL
and	NULL
be	NULL
within	NULL
the	NULL
dynamic	NULL
range	NULL
of	NULL
the	NULL
detectors	NULL
.	NULL

Assay	NULL
for	NULL
activation	NULL
by	NULL
LMPI	NULL
.	NULL

Cell	NULL
lines	NULL
were	NULL
cotransfected	NULL
with	NULL
5	NULL
ug	NULL
each	NULL
of	NULL
the	NULL
plasmids	NULL
«	NULL
B.CONA.LUC	NULL
and	NULL
pCMV.LTR.GH	NULL
and	NULL
cither	NULL
pCMVLMPI	NULL
or	NULL
the	NULL
pCMVLMPA	NULL
control	NULL
plasmid	NULL
.	NULL

The	NULL
electroporated	NULL
cells	NULL
were	NULL
transferred	NULL
to	NULL
6	NULL
ml	NULL
of	NULL
growth	NULL
medium	NULL
,	NULL
and	NULL
replicate	NULL
1-ml	NULL
cultures	NULL
were	NULL
set	NULL
up	NULL
.	NULL

At	NULL
24	NULL
h	NULL
postelectroporation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
was	NULL
determined	NULL
by	NULL
quantita-tion	NULL
of	NULL
luciferase	NULL
activity	NULL
in	NULL
a	NULL
bioluminescence	NULL
assay	NULL
.	NULL

To	NULL
control	NULL
for	NULL
variation	NULL
in	NULL
transfection	NULL
efficiency	NULL
between	NULL
different	NULL
samples	NULL
,	NULL
the	NULL
culture	NULL
supernatants	NULL
were	NULL
also	NULL
harvested	NULL
and	NULL
the	NULL
amount	NULL
of	NULL
secreted	NULL
human	NULL
growth	NULL
hormone	NULL
(	NULL
hGH	NULL
)	NULL
(	NULL
expressed	NULL
from	NULL
the	NULL
cotransfected	NULL
pCMV.LTR.GH	NULL
)	NULL
was	NULL
measured	NULL
by	NULL
a	NULL
sandwich	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
(	NULL
ELISA	NULL
)	NULL
.	NULL

The	NULL
relative	NULL
NF-KB	NULL
activity	NULL
for	NULL
each	NULL
transfected	NULL
sample	NULL
was	NULL
calculated	NULL
by	NULL
dividing	NULL
the	NULL
luciferase	NULL
activity	NULL
by	NULL
the	NULL
amount	NULL
of	NULL
hGH	NULL
secreted	NULL
.	NULL

Bioluminescence	NULL
assay	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

The	NULL
assay	NULL
used	NULL
was	NULL
a	NULL
modification	NULL
of	NULL
the	NULL
technique	NULL
of	NULL
de	NULL
Wet	NULL
et	NULL
al	NULL
.	NULL

(	NULL
10	NULL
)	NULL
.	NULL

Transfectants	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
PBS	NULL
and	NULL
then	NULL
lysed	NULL
in	NULL
400	NULL
to	NULL
500	NULL
pl	NULL
of	NULL
assay	NULL
buffer	NULL
(	NULL
100	NULL
mM	NULL
sodium	NULL
phosphate	NULL
[	NULL
pH	NULL
8.0	NULL
]	NULL
,	NULL
5	NULL
mM	NULL
magnesium	NULL
chloride	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
)	NULL
.	NULL

Cellular	NULL
debris	NULL
was	NULL
removed	NULL
by	NULL
a	NULL
brief	NULL
centrifugation	NULL
,	NULL
and	NULL
then	NULL
300	NULL
pl	NULL
of	NULL
the	NULL
lysate	NULL
was	NULL
transferred	NULL
to	NULL
a	NULL
scintillation	NULL
tube	NULL
containing	NULL
30	NULL
pl	NULL
of	NULL
25	NULL
mM	NULL
ATP	NULL
and	NULL
analyzed	NULL
in	NULL
a	NULL
Berthold	NULL
LB	NULL
9501	NULL
luminometer	NULL
.	NULL

Light	NULL
release	NULL
was	NULL
integrated	NULL
for	NULL
10	NULL
s	NULL
commencing	NULL
5	NULL
s	NULL
after	NULL
the	NULL
injection	NULL
of	NULL
100	NULL
pl	NULL
of	NULL
0.5	NULL
mM	NULL
luciferin	NULL
dissolved	NULL
in	NULL
30	NULL
mM	NULL
glycylglycine	NULL
buffer	NULL
,	NULL
pH	NULL
8.0	NULL
.	NULL

ELISA	NULL
for	NULL
hGH	NULL
.	NULL

Wells	NULL
of	NULL
Immulon-1	NULL
micro-ELISA	NULL
plates	NULL
(	NULL
Dynatech	NULL
)	NULL
were	NULL
coated	NULL
with	NULL
a	NULL
murine	NULL
MAb	NULL
to	NULL
hGH	NULL
(	NULL
2FI0	NULL
;	NULL
Biogenesis	NULL
,	NULL
4750-0316	NULL
)	NULL
by	NULL
incubating	NULL
them	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
MAb	NULL
per	NULL
ml	NULL
in	NULL
0.1	NULL
M	NULL
bicarbonate	NULL
buffer	NULL
(	NULL
pH	NULL
9.5	NULL
)	NULL
at	NULL
4°C	NULL
overnight	NULL
.	NULL

The	NULL
plates	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
PBS	NULL
containing	NULL
0.1	NULL
%	NULL
Tween-20	NULL
and	NULL
were	NULL
blocked	NULL
at	NULL
37°C	NULL
for	NULL
1	NULL
h	NULL
with	NULL
1	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
in	NULL
PBS-Tween	NULL
.	NULL

Plates	NULL
were	NULL
then	NULL
given	NULL
a	NULL
further	NULL
three	NULL
washes	NULL
in	NULL
PBS-Tween	NULL
before	NULL
incubation	NULL
with	NULL
50	NULL
pul	NULL
of	NULL
the	NULL
test	NULL
samples	NULL
for	NULL
2	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Culture	NULL
supernatants	NULL
from	NULL
the	NULL
hGH-transfected	NULL
cells	NULL
were	NULL
tested	NULL
in	NULL
duplicate	NULL
,	NULL
both	NULL
undiluted	NULL
and	NULL
diluted	NULL
1:10	NULL
in	NULL
PBS	NULL
.	NULL

The	NULL
plates	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
PBS-Tween	NULL
and	NULL
then	NULL
incubated	NULL
for	NULL
1.5	NULL
h	NULL
with	NULL
a	NULL
1/2,000	NULL
dilution	NULL
of	NULL
sheep	NULL
anti-hGH	NULL
antibodies	NULL
(	NULL
Biogenesis	NULL
,	NULL
4750-0254	NULL
)	NULL
.	NULL

After	NULL
three	NULL
further	NULL
washes	NULL
with	NULL
PBS-Tween	NULL
,	NULL
the	NULL
plates	NULL
were	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
horseradish	NULL
peroxidase-conjugated	NULL
rabbit	NULL
antibodies	NULL
to	NULL
sheep	NULL
IgG	NULL
(	NULL
Sigma	NULL
,	NULL
A3415	NULL
)	NULL
diluted	NULL
1/4,000	NULL
.	NULL

Following	NULL
five	NULL
washes	NULL
with	NULL
PBS-Tween	NULL
,	NULL
the	NULL
plates	NULL
were	NULL
developed	NULL
with	NULL
1,2-phenylenediamine	NULL
(	NULL
DAKO	NULL
,	NULL
$	NULL
-2000	NULL
)	NULL
in	NULL
0.1	NULL
M	NULL
citric	NULL
acid-phosphate	NULL
buffer	NULL
for	NULL
5	NULL
min	NULL
before	NULL
the	NULL
reaction	NULL
was	NULL
terminated	NULL
with	NULL
H	NULL
,	NULL
SO	NULL
,	NULL
and	NULL
optical	NULL
densities	NULL
were	NULL
measured	NULL
at	NULL
490	NULL
nm	NULL
.	NULL

The	NULL
concentration	NULL
of	NULL
hGH	NULL
in	NULL
the	NULL
test	NULL
samples	NULL
was	NULL
calculated	NULL
from	NULL
a	NULL
standard	NULL
curve	NULL
constructed	NULL
from	NULL
the	NULL
results	NULL
obtained	NULL
with	NULL
duplicate	NULL
doubling	NULL
dilutions	NULL
of	NULL
a	NULL
100-ng/ml	NULL
hGH	NULL
standard	NULL
.	NULL

The	NULL
useful	NULL
range	NULL
of	NULL
this	NULL
ELISA	NULL
was	NULL
2	NULL
to	NULL
40	NULL
ng	NULL
of	NULL
hGH	NULL
per	NULL
ml	NULL
.	NULL

RESULTS	NULL
LMP1	NULL
induction	NULL
in	NULL
stable	NULL
clones	NULL
causes	NULL
upregulation	NULL
of	NULL
adhesion	NULL
molecules	NULL
and	NULL
Bel-2	NULL
.	NULL

In	NULL
the	NULL
first	NULL
set	NULL
of	NULL
experiments	NULL
,	NULL
ELI-BL	NULL
was	NULL
transfected	NULL
with	NULL
pSV2.gpt.MTLM	NULL
,	NULL
which	NULL
is	NULL
a	NULL
drug-selectable	NULL
DNA	NULL
vector	NULL
containing	NULL
the	NULL
LMPI	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
an	NULL
inducible	NULL
metallothionein	NULL
promoter	NULL
.	NULL

The	NULL
transfected	NULL
cells	NULL
were	NULL
selected	NULL
with	NULL
mycophenolic	NULL
acid	NULL
,	NULL
and	NULL
stable	NULL
drug-resistant	NULL
clones	NULL
were	NULL
expanded	NULL
and	NULL
analyzed	NULL
for	NULL
Vor	NULL
.	NULL

68	NULL
,	NULL
1994	NULL
A	NULL
1407	NULL
MTLM	NULL
.	NULL

2	NULL
&	NULL
1201	NULL
©	NULL
LCL	NULL
®	NULL
]	NULL
-A-z	NULL
100	NULL
®	NULL
2	NULL
-	NULL
807	NULL
8	NULL
9	NULL
MTLM	NULL
.1	NULL
®	NULL
-	NULL
607	NULL
6	NULL
3	NULL
LL	NULL
401	NULL
C	NULL
C	NULL
®	NULL
C	NULL
{	NULL
{	NULL
parent	NULL
0	NULL
T	NULL
T	NULL
T	NULL
T	NULL
0	NULL
1	NULL
2	NULL
3	NULL
Time	NULL
(	NULL
days	NULL
)	NULL
post-induction	NULL
B	NULL
240	NULL
7	NULL
MTLM	NULL
.	NULL

2	NULL
a	NULL
>	NULL
2007	NULL
®	NULL
&	NULL
8	NULL
€	NULL
1601	NULL
8	NULL
MTLM	NULL
.1	NULL
5	NULL
8	NULL
120	NULL
@	NULL
LCL	NULL
g	NULL
807	NULL
k-LL	NULL
c	NULL
gpt	NULL
.	NULL

1	NULL
s	NULL
arent	NULL
<	NULL
p	NULL
0	NULL
T	NULL
T	NULL
T	NULL
t	NULL
0	NULL
1	NULL
2	NULL
3	NULL
Time	NULL
(	NULL
days	NULL
)	NULL
post-induction	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Kinetics	NULL
of	NULL
LFA-3	NULL
(	NULL
A	NULL
)	NULL
and	NULL
ICAM-1	NULL
(	NULL
B	NULL
)	NULL
expression	NULL
following	NULL
cadmium-induced	NULL
expression	NULL
of	NULL
LMP	NULL
I	NULL
in	NULL
stably	NULL
transfected	NULL
clones	NULL
of	NULL
ELI-BL	NULL
.	NULL

Two	NULL
transfected	NULL
clones	NULL
carrying	NULL
the	NULL
metallothionein-driven	NULL
LMP	NULL
1	NULL
gene	NULL
(	NULL
MTLM.1	NULL
and	NULL
MTLM.2	NULL
)	NULL
were	NULL
compared	NULL
with	NULL
the	NULL
parental	NULL
ELI-BL	NULL
line	NULL
(	NULL
parent	NULL
)	NULL
and	NULL
with	NULL
a	NULL
clone	NULL
transfected	NULL
with	NULL
the	NULL
LMP	NULL
!	NULL

-negative	NULL
control	NULL
vector	NULL
DNA	NULL
(	NULL
gpt.1	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
treated	NULL
with	NULL
6	NULL
uM	NULL
cadmium	NULL
chloride	NULL
,	NULL
and	NULL
replicate	NULL
cultures	NULL
were	NULL
harvested	NULL
at	NULL
the	NULL
time	NULL
points	NULL
shown	NULL
for	NULL
immunofluorescence	NULL
staining	NULL
with	NULL
the	NULL
MAbs	NULL
TS/2.9	NULL
(	NULL
anti-LFA-3	NULL
)	NULL
and	NULL
(	NULL
anti-ICAM-1	NULL
)	NULL
followed	NULL
by	NULL
flow	NULL
cytometric	NULL
analysis	NULL
.	NULL

Immunofluorescence	NULL
intensity	NULL
was	NULL
analyzed	NULL
on	NULL
a	NULL
linear	NULL
scale	NULL
,	NULL
and	NULL
the	NULL
mean	NULL
fluorescence	NULL
intensity	NULL
(	NULL
arbitary	NULL
units	NULL
)	NULL
was	NULL
determined	NULL
.	NULL

The	NULL
mean	NULL
fluorescence	NULL
intensity	NULL
of	NULL
a	NULL
normal	NULL
EBV-transformed	NULL
LCL	NULL
was	NULL
analyzed	NULL
for	NULL
comparison	NULL
,	NULL
and	NULL
the	NULL
results	NULL
are	NULL
indicated	NULL
with	NULL
a	NULL
solid	NULL
triangle	NULL
.	NULL

inducible	NULL
LMPI1	NULL
expression	NULL
.	NULL

The	NULL
selected	NULL
stable	NULL
clones	NULL
expressed	NULL
different	NULL
basal	NULL
levels	NULL
of	NULL
LMP1	NULL
from	NULL
the	NULL
metallothionein	NULL
promoter	NULL
,	NULL
but	NULL
some	NULL
clones	NULL
were	NULL
found	NULL
to	NULL
have	NULL
low	NULL
basal	NULL
expression	NULL
and	NULL
to	NULL
be	NULL
particularly	NULL
responsive	NULL
to	NULL
induction	NULL
by	NULL
the	NULL
heavy	NULL
metals	NULL
.	NULL

Titration	NULL
experiments	NULL
showed	NULL
that	NULL
6	NULL
M	NULL
cadmium	NULL
chloride	NULL
regularly	NULL
gave	NULL
maximal	NULL
induction	NULL
of	NULL
LMPI	NULL
within	NULL
5	NULL
to	NULL
9	NULL
h	NULL
in	NULL
all	NULL
inducible	NULL
clones	NULL
.	NULL

Most	NULL
importantly	NULL
,	NULL
this	NULL
concentration	NULL
of	NULL
cadmium	NULL
was	NULL
usually	NULL
nontoxic	NULL
,	NULL
as	NULL
judged	NULL
by	NULL
cell	NULL
viability	NULL
and	NULL
proliferation	NULL
,	NULL
when	NULL
added	NULL
to	NULL
control	NULL
cultures	NULL
for	NULL
a	NULL
period	NULL
of	NULL
up	NULL
to	NULL
3	NULL
days	NULL
.	NULL

Figures	NULL
1	NULL
and	NULL
2	NULL
illustrate	NULL
the	NULL
effect	NULL
of	NULL
6	NULL
wM	NULL
cadmium	NULL
chloride	NULL
upon	NULL
the	NULL
cellular	NULL
phenotype	NULL
of	NULL
two	NULL
transfectants	NULL
of	NULL
the	NULL
ELI-BL	NULL
line	NULL
(	NULL
ELI-MTLM.1	NULL
and	NULL
ELI-MTLM.2	NULL
)	NULL
compared	NULL
with	NULL
the	NULL
parental	NULL
ELI-BL	NULL
line	NULL
and	NULL
with	NULL
a	NULL
drug-resistant	NULL
vector	NULL
control	NULL
transfectant	NULL
(	NULL
ELI-gpt.1	NULL
)	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
,	NULL
INDUCTION	NULL
OF	NULL
Bel-2	NULL
BY	NULL
LMP	NULL
!	NULL

5605	NULL
ELI-BL	NULL
LI-BL	NULL
ELI-BL	NULL
gpt	NULL
.	NULL

1	NULL
MTLM.1	NULL
MTLM.2	NULL
g	NULL
L	NULL
1	NULL
T	NULL
1	NULL
-	NULL
1	NULL
S3	NULL
0	NULL
0	NULL
1.2208	NULL
051	NULL
L20.3	NULL
0	NULL
=1	NULL
12083	NULL
©	NULL
_	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Western	NULL
blots	NULL
illustrating	NULL
the	NULL
kinetics	NULL
of	NULL
LMP1	NULL
and	NULL
Bcl-2	NULL
expression	NULL
following	NULL
cadmium	NULL
induction	NULL
in	NULL
ELI-BL	NULL
lines	NULL
stably	NULL
transfected	NULL
with	NULL
the	NULL
metallothionein-driven	NULL
LMP1	NULL
gene	NULL
.	NULL

The	NULL
gpt.1	NULL
control	NULL
transfectant	NULL
and	NULL
the	NULL
MTLM.1	NULL
and	NULL
MTLM.2	NULL
LMP1	NULL
gene	NULL
transfectants	NULL
were	NULL
treated	NULL
with	NULL
6	NULL
uM	NULL
cadmium	NULL
and	NULL
harvested	NULL
at	NULL
0	NULL
,	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
3	NULL
days	NULL
as	NULL
for	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Cells	NULL
were	NULL
solubilized	NULL
and	NULL
separated	NULL
by	NULL
Laemmli	NULL
SDS-PAGE	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
,	NULL
and	NULL
replicate	NULL
blots	NULL
were	NULL
probed	NULL
with	NULL
MAb	NULL
CS.1-4	NULL
(	NULL
anti-LMP1	NULL
,	NULL
top	NULL
panel	NULL
)	NULL
or	NULL
bel-2/124	NULL
(	NULL
anti-Bcl-2	NULL
,	NULL
bottom	NULL
panel	NULL
)	NULL
.	NULL

compared	NULL
with	NULL
the	NULL
control	NULL
clones	NULL
,	NULL
the	NULL
MTLM	NULL
clones	NULL
showed	NULL
significantly	NULL
higher	NULL
expression	NULL
of	NULL
the	NULL
adhesion	NULL
molecules	NULL
LFA-3	NULL
and	NULL
ICAM-1	NULL
even	NULL
before	NULL
treatment	NULL
with	NULL
cadmium	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
;	NULL
this	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
basal	NULL
expression	NULL
of	NULL
LMPI	NULL
detected	NULL
in	NULL
these	NULL
clones	NULL
when	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
the	NULL
MTLM	NULL
clones	NULL
with	NULL
cadmium	NULL
led	NULL
to	NULL
induction	NULL
of	NULL
the	NULL
adhesion	NULL
molecules	NULL
LFA-3	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
and	NULL
ICAM-1	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
within	NULL
24	NULL
h	NULL
,	NULL
with	NULL
a	NULL
maximum	NULL
induction	NULL
being	NULL
achieved	NULL
by	NULL
48	NULL
h.	NULL
Cadmium	NULL
caused	NULL
no	NULL
such	NULL
phenotypic	NULL
effect	NULL
in	NULL
the	NULL
control	NULL
gpt.1	NULL
clone	NULL
or	NULL
in	NULL
the	NULL
parental	NULL
ELI-BL	NULL
line	NULL
.	NULL

The	NULL
Western	NULL
blots	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
illustrate	NULL
that	NULL
maximum	NULL
induction	NULL
of	NULL
LMPI1	NULL
by	NULL
cadmium	NULL
in	NULL
this	NULL
system	NULL
was	NULL
achieved	NULL
within	NULL
24	NULL
h	NULL
and	NULL
that	NULL
the	NULL
induced	NULL
levels	NULL
were	NULL
comparable	NULL
to	NULL
,	NULL
or	NULL
in	NULL
excess	NULL
of	NULL
,	NULL
the	NULL
levels	NULL
of	NULL
LMPI	NULL
in	NULL
normal	NULL
EBV	NULL
LCLs	NULL
.	NULL

Parallel	NULL
blots	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
probed	NULL
with	NULL
anti-Bcl-2	NULL
antibodies	NULL
demonstrated	NULL
a	NULL
temporal	NULL
increase	NULL
in	NULL
Bcl-2	NULL
expression	NULL
in	NULL
the	NULL
cadmium-treated	NULL
MTLM	NULL
transfectants	NULL
and	NULL
no	NULL
change	NULL
in	NULL
the	NULL
cadmium-treated	NULL
control	NULL
gpt	NULL
transfectant	NULL
.	NULL

Cadmium-induced	NULL
expression	NULL
of	NULL
LMP	NULL
1	NULL
in	NULL
the	NULL
MTLM	NULL
transfectants	NULL
did	NULL
not	NULL
have	NULL
any	NULL
effect	NULL
upon	NULL
cell	NULL
viability	NULL
during	NULL
the	NULL
time	NULL
span	NULL
of	NULL
these	NULL
experiments	NULL
,	NULL
and	NULL
immunofiuo-rescence	NULL
staining	NULL
of	NULL
fixed-cell	NULL
smears	NULL
showed	NULL
that	NULL
induction	NULL
of	NULL
both	NULL
LMP1	NULL
and	NULL
Bel-2	NULL
expression	NULL
occurs	NULL
uniformly	NULL
in	NULL
all	NULL
cells	NULL
within	NULL
the	NULL
cadmium-treated	NULL
cultures	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Similar	NULL
data	NULL
were	NULL
obtained	NULL
with	NULL
a	NULL
series	NULL
of	NULL
stable	NULL
clones	NULL
of	NULL
BL41	NULL
transfected	NULL
with	NULL
the	NULL
inducible	NULL
MTLM	NULL
expression	NULL
vector	NULL
.	NULL

Adhesion	NULL
molecules	NULL
were	NULL
induced	NULL
with	NULL
kinetics	NULL
similar	NULL
to	NULL
those	NULL
observed	NULL
with	NULL
the	NULL
ELI-MTLM	NULL
clones	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
Bcl-2	NULL
expression	NULL
again	NULL
lagged	NULL
behind	NULL
that	NULL
of	NULL
LMP1	NULL
and	NULL
ICAM-1	NULL
.	NULL

As	NULL
illustrated	NULL
by	NULL
two	NULL
representative	NULL
clones	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
maximal	NULL
Bel-2	NULL
expression	NULL
was	NULL
not	NULL
achieved	NULL
until	NULL
2	NULL
to	NULL
3	NULL
days	NULL
after	NULL
addition	NULL
of	NULL
cadmium	NULL
.	NULL

Throughout	NULL
these	NULL
experiments	NULL
,	NULL
upregulation	NULL
of	NULL
Bel-2	NULL
by	NULL
LMPI	NULL
was	NULL
consistently	NULL
observed	NULL
,	NULL
but	NULL
there	NULL
was	NULL
no	NULL
obvious	NULL
correlation	NULL
between	NULL
LMP	NULL
1	NULL
levels	NULL
and	NULL
the	NULL
levels	NULL
or	NULL
kinetics	NULL
of	NULL
Bel-2	NULL
induction	NULL
.	NULL

For	NULL
5606	NULL
ROWE	NULL
ET	NULL
AL	NULL
.	NULL

BL41	NULL
BL41	NULL
BL41	NULL
gpt	NULL
.	NULL

1	NULL
MTLM.4	NULL
MTLM.11	NULL
m	NULL
I	NULL
if	NULL
1-4	NULL
1	NULL
_	NULL
<	NULL
3	NULL
o	NULL
_	NULL
0	NULL
:	NULL
1	NULL
-2	NULL
``	NULL
3	NULL
0-1	NULL
.	NULL

2	NULL
3	NULL
051.2	NULL
/	NULL
.3	NULL
Q	NULL
LMP1	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Western	NULL
blots	NULL
illustrating	NULL
the	NULL
kinetics	NULL
of	NULL
LMP1	NULL
and	NULL
Bcl-2	NULL
expression	NULL
following	NULL
cadmium	NULL
induction	NULL
in	NULL
BL41	NULL
lines	NULL
stably	NULL
transfected	NULL
with	NULL
the	NULL
metallothionein-driven	NULL
LMP1	NULL
gene	NULL
.	NULL

The	NULL
gpt.1	NULL
control	NULL
transfectant	NULL
and	NULL
the	NULL
MTLM.4	NULL
and	NULL
MTLM.11	NULL
LMP1	NULL
gene	NULL
transfectants	NULL
were	NULL
treated	NULL
with	NULL
6	NULL
M	NULL
cadmium	NULL
and	NULL
analyzed	NULL
as	NULL
for	NULL
Fig	NULL
.	NULL

2.	NULL
example	NULL
,	NULL
lower	NULL
levels	NULL
of	NULL
LMP1	NULL
were	NULL
induced	NULL
in	NULL
the	NULL
BL41-MTLM.4	NULL
clone	NULL
compared	NULL
with	NULL
the	NULL
BL41.MTLM.11	NULL
clone	NULL
,	NULL
but	NULL
the	NULL
levels	NULL
of	NULL
Bcl-2	NULL
induced	NULL
in	NULL
the	NULL
MTLM.4	NULL
clone	NULL
were	NULL
consistently	NULL
higher	NULL
than	NULL
those	NULL
in	NULL
the	NULL
MTLM.11	NULL
clone	NULL
.	NULL

Furthermore	NULL
,	NULL
maximum	NULL
induction	NULL
of	NULL
Bel-2	NULL
was	NULL
achieved	NULL
by	NULL
48	NULL
h	NULL
in	NULL
the	NULL
MTLM.4	NULL
clone	NULL
,	NULL
compared	NULL
with	NULL
72	NULL
h	NULL
in	NULL
the	NULL
MTLM.11	NULL
clone	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

LMP1	NULL
induction	NULL
in	NULL
stable	NULL
clones	NULL
causes	NULL
activation	NULL
of	NULL
NF-B	NULL
.	NULL

Since	NULL
other	NULL
workers	NULL
have	NULL
shown	NULL
that	NULL
LMP1	NULL
mediates	NULL
at	NULL
least	NULL
some	NULL
of	NULL
its	NULL
effects	NULL
through	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
18	NULL
,	NULL
26	NULL
)	NULL
,	NULL
we	NULL
asked	NULL
whether	NULL
NF-kB	NULL
activation	NULL
occurred	NULL
in	NULL
the	NULL
stable	NULL
MTLM	NULL
clones	NULL
following	NULL
induction	NULL
of	NULL
LMP1	NULL
by	NULL
cadmium	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
activity	NULL
was	NULL
assayed	NULL
with	NULL
the	NULL
kB.CONA.LUC	NULL
reporter	NULL
DNA	NULL
construct	NULL
in	NULL
which	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
expression	NULL
is	NULL
under	NULL
the	NULL
control	NULL
of	NULL
a	NULL
conalbumin	NULL
promoter	NULL
regulated	NULL
by	NULL
three	NULL
repeated	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
motifs	NULL
.	NULL

The	NULL
ELI-MTLM.2	NULL
and	NULL
BL41-MTLM.4	NULL
lines	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
reporter	NULL
DNA	NULL
,	NULL
and	NULL
replicate	NULL
cultures	NULL
were	NULL
then	NULL
set	NULL
up	NULL
with	NULL
and	NULL
without	NULL
6	NULL
M	NULL
cadmium	NULL
chloride	NULL
.	NULL

At	NULL
16	NULL
h	NULL
after	NULL
electroporation	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
LMP1	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
paralleled	NULL
by	NULL
induced	NULL
synthesis	NULL
of	NULL
luciferase	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

No	NULL
induction	NULL
of	NULL
luciferase	NULL
synthesis	NULL
was	NULL
observed	NULL
in	NULL
control	NULL
ELI-gpt	NULL
and	NULL
BL41-gpt	NULL
lines	NULL
transfected	NULL
with	NULL
the	NULL
reporter	NULL
and	NULL
treated	NULL
with	NULL
cadmium	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
this	NULL
reporter	NULL
assay	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
was	NULL
confirmed	NULL
in	NULL
control	NULL
experiments	NULL
which	NULL
showed	NULL
that	NULL
there	NULL
was	NULL
no	NULL
LMP1-induced	NULL
expression	NULL
of	NULL
luciferase	NULL
from	NULL
the	NULL
CONA.LUC	NULL
control	NULL
plasmid	NULL
which	NULL
lacked	NULL
the	NULL
kB	NULL
binding	NULL
sites	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
experiments	NULL
therefore	NULL
showed	NULL
that	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
an	NULL
early	NULL
consequence	NULL
of	NULL
induced	NULL
LMP1	NULL
expression	NULL
in	NULL
B	NULL
lymphocytes	NULL
.	NULL

Transient	NULL
expression	NULL
of	NULL
LMP1	NULL
induces	NULL
Bcl-2	NULL
in	NULL
transfected	NULL
B-cell	NULL
lines	NULL
.	NULL

In	NULL
the	NULL
second	NULL
set	NULL
of	NULL
experiments	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
transient	NULL
LMP1	NULL
expression	NULL
to	NULL
induce	NULL
Bel-2	NULL
was	NULL
investigated	NULL
in	NULL
several	NULL
different	NULL
cell	NULL
lines	NULL
following	NULL
electroporation	NULL
with	NULL
the	NULL
pCMVLMP1	NULL
plasmid	NULL
.	NULL

Expression	NULL
of	NULL
LMP1	NULL
from	NULL
pCMVLMP1	NULL
is	NULL
driven	NULL
by	NULL
the	NULL
strong	NULL
constitutive	NULL
CMV	NULL
promoter	NULL
,	NULL
and	NULL
previous	NULL
transient	NULL
expression	NULL
studies	NULL
using	NULL
this	NULL
plasmid	NULL
have	NULL
demonstrated	NULL
that	NULL
expression	NULL
of	NULL
the	NULL
LMP1	NULL
gene	NULL
results	NULL
in	NULL
upregulation	NULL
of	NULL
cell	NULL
surface	NULL
ICAM-1	NULL
within	NULL
24	NULL
h	NULL
(	NULL
40	NULL
)	NULL
.	NULL

This	NULL
J.	NULL
ViroL	NULL
.	NULL

BL41	NULL
_	NULL
3	NULL
5.006	NULL
[	NULL
Z	NULL
.	NULL

8	NULL
LMP1-B	NULL
3	NULL
2	NULL
e	NULL
|	NULL
®	NULL
2	NULL
{	NULL
0	NULL
®	NULL
Co	NULL
20	NULL
1	NULL
4	NULL
O	NULL
h	NULL
j	NULL
hd	NULL
4	NULL
0	NULL
Cadmium	NULL
-	NULL
+	NULL
-	NULL
+	NULL
o-	NULL
+00	NULL
o-	NULL
+	NULL
gpt	NULL
MTLM	NULL
gpt	NULL
MTLM	NULL
L	NULL
J	NULL
L.	NULL
]	NULL
Eli-BL	NULL
BL41	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
by	NULL
LMP1	NULL
in	NULL
BL	NULL
lines	NULL
stably	NULL
transfected	NULL
with	NULL
an	NULL
inducible	NULL
LMP1	NULL
gene	NULL
.	NULL

Control	NULL
and	NULL
LMP1	NULL
gene-transfected	NULL
lines	NULL
of	NULL
ELI-BL	NULL
(	NULL
gpt.1	NULL
and	NULL
MTLM.2	NULL
[	NULL
Fig	NULL
.	NULL

2	NULL
]	NULL
)	NULL
and	NULL
BL41	NULL
(	NULL
gpt.1	NULL
and	NULL
MTLM.4	NULL
[	NULL
Fig	NULL
.	NULL

3	NULL
]	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
NF-kB	NULL
luciferase	NULL
reporter	NULL
DNA	NULL
,	NULL
and	NULL
then	NULL
replicate	NULL
cultures	NULL
were	NULL
treated	NULL
with	NULL
or	NULL
without	NULL
6	NULL
wM	NULL
cadmium	NULL
chloride	NULL
.	NULL

After	NULL
16	NULL
h	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
analyzed	NULL
for	NULL
LMP1	NULL
expression	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
the	NULL
CS.1-4	NULL
MAb	NULL
(	NULL
A	NULL
)	NULL
and	NULL
for	NULL
NF-kB	NULL
activity	NULL
by	NULL
measuring	NULL
luciferase	NULL
activity	NULL
(	NULL
B	NULL
)	NULL
.	NULL

earlier	NULL
study	NULL
employed	NULL
flow-cytometric	NULL
analysis	NULL
of	NULL
immunofiu-orescence	NULL
staining	NULL
on	NULL
viable	NULL
cells	NULL
to	NULL
analyze	NULL
induction	NULL
of	NULL
cell	NULL
surface	NULL
markers	NULL
in	NULL
cell	NULL
lines	NULL
which	NULL
showed	NULL
efficient	NULL
transfection	NULL
efficiency	NULL
.	NULL

The	NULL
present	NULL
experiments	NULL
employed	NULL
immunofluorescence	NULL
staining	NULL
of	NULL
fixed-cell	NULL
smears	NULL
,	NULL
followed	NULL
by	NULL
confocal	NULL
microscopy	NULL
;	NULL
this	NULL
is	NULL
a	NULL
more	NULL
sensitive	NULL
assay	NULL
for	NULL
monitoring	NULL
intracellular	NULL
markers	NULL
such	NULL
as	NULL
LMP1	NULL
and	NULL
Bcl-2	NULL
and	NULL
suitable	NULL
even	NULL
for	NULL
target	NULL
lines	NULL
which	NULL
transfect	NULL
with	NULL
relatively	NULL
poor	NULL
efficiency	NULL
.	NULL

Figure	NULL
5	NULL
illustrates	NULL
representative	NULL
results	NULL
obtained	NULL
following	NULL
transfection	NULL
of	NULL
two	NULL
BL	NULL
lines	NULL
,	NULL
DG75	NULL
and	NULL
BJAB	NULL
,	NULL
and	NULL
the	NULL
proerythromyelocytic	NULL
cell	NULL
line	NULL
K562	NULL
.	NULL

At	NULL
72	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cell	NULL
smears	NULL
were	NULL
fixed	NULL
and	NULL
stained	NULL
for	NULL
LMP1	NULL
,	NULL
ICAM-1	NULL
,	NULL
and	NULL
Bcl-2	NULL
with	NULL
FITC-conjugated	NULL
antibodies	NULL
(	NULL
green	NULL
,	NULL
or	NULL
yellow	NULL
with	NULL
intense	NULL
staining	NULL
)	NULL
,	NULL
and	NULL
the	NULL
nuclei	NULL
were	NULL
counterstained	NULL
red	NULL
with	NULL
propidium	NULL
iodide	NULL
.	NULL

DG75	NULL
cells	NULL
transfected	NULL
with	NULL
control	NULL
vector	NULL
(	NULL
top	NULL
row	NULL
,	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
were	NULL
negative	NULL
for	NULL
LMP	NULL
1	NULL
,	NULL
showed	NULL
intermediate	NULL
levels	NULL
of	NULL
ICAM-1	NULL
staining	NULL
,	NULL
and	NULL
stained	NULL
negative	NULL
for	NULL
Bcl-2	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
DG75	NULL
cells	NULL
transfected	NULL
with	NULL
pCMVLMP1	NULL
(	NULL
second	NULL
row	NULL
,	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
demonstrated	NULL
LMP1	NULL
expression	NULL
in	NULL
about	NULL
17	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
,	NULL
and	NULL
a	NULL
smaller	NULL
subpopulation	NULL
clearly	NULL
showed	NULL
marked	NULL
VoL	NULL
.	NULL

68	NULL
,	NULL
1994	NULL
DG7S	NULL
vector	NULL
DG75	NULL
-+	NULL
LMP1	NULL
BJAB	NULL
LMP	NULL
1	NULL
K562	NULL
+	NULL
LMP	NULL
1	NULL
INDUCTION	NULL
OF	NULL
Bel-2	NULL
BY	NULL
LMPI1	NULL
5607	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Single-cell	NULL
analysis	NULL
by	NULL
confocal	NULL
microscopy	NULL
of	NULL
LMP1	NULL
,	NULL
ICAM-1	NULL
,	NULL
and	NULL
Bel-2	NULL
expression	NULL
in	NULL
cell	NULL
lines	NULL
transiently	NULL
expressing	NULL
LMP1	NULL
.	NULL

Cell	NULL
lines	NULL
(	NULL
DG75	NULL
,	NULL
BJAB	NULL
,	NULL
and	NULL
K562	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
vector	NULL
control	NULL
DNA	NULL
(	NULL
top	NULL
row	NULL
)	NULL
or	NULL
with	NULL
DNA	NULL
containing	NULL
a	NULL
CMV	NULL
promoter-driven	NULL
LMP1	NULL
gene	NULL
(	NULL
rows	NULL
2	NULL
,	NULL
3	NULL
,	NULL
and	NULL
4	NULL
)	NULL
,	NULL
and	NULL
after	NULL
72	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
for	NULL
preparation	NULL
of	NULL
smears	NULL
on	NULL
slides	NULL
.	NULL

The	NULL
slides	NULL
were	NULL
fixed	NULL
in	NULL
acetone-methanol	NULL
and	NULL
then	NULL
stained	NULL
with	NULL
the	NULL
MAbs	NULL
CS.1-4	NULL
(	NULL
anti-LMP1	NULL
,	NULL
column	NULL
1	NULL
)	NULL
,	NULL
RR/1	NULL
(	NULL
anti-ICAM-1	NULL
,	NULL
column	NULL
2	NULL
)	NULL
,	NULL
and	NULL
bel-2/124	NULL
(	NULL
anti-Bcl-2	NULL
,	NULL
column	NULL
3	NULL
)	NULL
followed	NULL
by	NULL
a	NULL
FITC-conjugated	NULL
anti-mouse	NULL
IgG	NULL
second-step	NULL
reagent	NULL
.	NULL

Before	NULL
being	NULL
analyzed	NULL
on	NULL
the	NULL
confocal	NULL
microscope	NULL
,	NULL
the	NULL
nuclei	NULL
were	NULL
counterstained	NULL
red	NULL
with	NULL
propidium	NULL
iodide	NULL
.	NULL

The	NULL
scale	NULL
bar	NULL
in	NULL
the	NULL
first	NULL
photograph	NULL
represents	NULL
10	NULL
pm	NULL
.	NULL

upregulated	NULL
expression	NULL
of	NULL
ICAM-1	NULL
(	NULL
7	NULL
%	NULL
)	NULL
and	NULL
Bel-2	NULL
(	NULL
4	NULL
%	NULL
)	NULL
.	NULL

The	NULL
BJAB	NULL
cell	NULL
line	NULL
(	NULL
third	NULL
row	NULL
,	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
showed	NULL
similar	NULL
LMPI-associated	NULL
upregulation	NULL
of	NULL
ICAM-1	NULL
and	NULL
Bcl-2	NULL
after	NULL
transfection	NULL
of	NULL
pCMVLMP1	NULL
.	NULL

However	NULL
,	NULL
whilst	NULL
the	NULL
expression	NULL
of	NULL
LMPL	NULL
in	NULL
the	NULL
K562	NULL
line	NULL
(	NULL
bottom	NULL
row	NULL
,	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
was	NULL
clearly	NULL
accompanied	NULL
by	NULL
induction	NULL
of	NULL
ICAM-1	NULL
,	NULL
there	NULL
was	NULL
no	NULL
detectable	NULL
upregulation	NULL
of	NULL
Bcl-2	NULL
.	NULL

Two-color	NULL
staining	NULL
for	NULL
ICAM-1	NULL
and	NULL
LMP1	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
top	NULL
panel	NULL
)	NULL
and	NULL
for	NULL
Bcl-2	NULL
and	NULL
LMP1	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
bottom	NULL
panel	NULL
)	NULL
in	NULL
DG75	NULL
cells	NULL
at	NULL
72	NULL
h	NULL
after	NULL
electroporation	NULL
with	NULL
pCMVLMPI	NULL
confirmed	NULL
that	NULL
both	NULL
of	NULL
these	NULL
cellular	NULL
markers	NULL
were	NULL
induced	NULL
in	NULL
the	NULL
LMP1-positive	NULL
subpopulation	NULL
of	NULL
cells	NULL
.	NULL

In	NULL
these	NULL
experiments	NULL
,	NULL
LMP1	NULL
was	NULL
stained	NULL
red	NULL
with	NULL
Texas	NULL
Red-conjugated	NULL
antibodies	NULL
whilst	NULL
ICAM-1	NULL
and	NULL
Bcl-2	NULL
were	NULL
stained	NULL
green	NULL
with	NULL
FITC-conjugated	NULL
antibodies	NULL
;	NULL
areas	NULL
of	NULL
colocalized	NULL
staining	NULL
appear	NULL
yellow	NULL
.	NULL

The	NULL
level	NULL
of	NULL
LMP1	NULL
expression	NULL
among	NULL
the	NULL
transfected	NULL
cell	NULL
population	NULL
varied	NULL
enormously	NULL
;	NULL
a	NULL
spectrum	NULL
of	NULL
staining	NULL
intensity	NULL
was	NULL
observed	NULL
from	NULL
very	NULL
weakly	NULL
stained	NULL
cells	NULL
through	NULL
cells	NULL
that	NULL
appeared	NULL
completely	NULL
saturated	NULL
with	NULL
LMP1I	NULL
.	NULL

As	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
and	NULL
6A	NULL
,	NULL
those	NULL
cells	NULL
showing	NULL
moderate	NULL
5608	NULL
ROWE	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
ICAM-1	NULL
ICAM-1	NULL
&	NULL
LMP1	NULL
dual	NULL
stain	NULL
Bcl-2	NULL
Bcl-2	NULL
&	NULL
LMP	NULL
1	NULL
dual	NULL
stain	NULL
ICAM-1	NULL
&	NULL
LMP1	NULL
dual	NULL
stain	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Confocal	NULL
micrographs	NULL
of	NULL
DG75	NULL
cells	NULL
3	NULL
days	NULL
after	NULL
electroporation	NULL
with	NULL
the	NULL
pCMVLMP1	NULL
DNA	NULL
,	NULL
illustrating	NULL
dual	NULL
staining	NULL
for	NULL
LMP1	NULL
and	NULL
ICAM-1	NULL
(	NULL
top	NULL
micrographs	NULL
)	NULL
and	NULL
for	NULL
LMP1	NULL
and	NULL
Bcl-2	NULL
(	NULL
bottom	NULL
micrographs	NULL
)	NULL
.	NULL

The	NULL
monochrome	NULL
photographs	NULL
are	NULL
enhanced-intensity	NULL
displays	NULL
of	NULL
the	NULL
fields	NULL
stained	NULL
for	NULL
ICAM-1	NULL
only	NULL
(	NULL
top	NULL
)	NULL
or	NULL
for	NULL
Bcl-2	NULL
only	NULL
(	NULL
bottom	NULL
)	NULL
,	NULL
which	NULL
serve	NULL
to	NULL
identify	NULL
all	NULL
the	NULL
cells	NULL
in	NULL
the	NULL
field	NULL
.	NULL

The	NULL
color	NULL
photographs	NULL
are	NULL
superimposed	NULL
images	NULL
of	NULL
LMP1	NULL
stained	NULL
red	NULL
with	NULL
Texas	NULL
Red	NULL
and	NULL
ICAM-1	NULL
or	NULL
Bcl-2	NULL
stained	NULL
green	NULL
with	NULL
FITC	NULL
;	NULL
areas	NULL
of	NULL
dual	NULL
staining	NULL
appear	NULL
yellow	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Confocal	NULL
micrographs	NULL
of	NULL
DG75	NULL
cells	NULL
3	NULL
days	NULL
after	NULL
electroporation	NULL
with	NULL
the	NULL
pCMVLMP1	NULL
DNA	NULL
,	NULL
illustrating	NULL
a	NULL
cell	NULL
grossly	NULL
overexpressing	NULL
LMP1	NULL
(	NULL
red	NULL
)	NULL
in	NULL
which	NULL
ICAM-1	NULL
(	NULL
green	NULL
)	NULL
was	NULL
barely	NULL
above	NULL
the	NULL
background	NULL
level	NULL
of	NULL
ICAM-1	NULL
staining	NULL
in	NULL
untransfected	NULL
cells	NULL
in	NULL
the	NULL
same	NULL
field	NULL
.	NULL

A	NULL
second	NULL
LMP1-positive	NULL
cell	NULL
in	NULL
the	NULL
field	NULL
expressed	NULL
LCL-like	NULL
amounts	NULL
of	NULL
the	NULL
viral	NULL
gene	NULL
and	NULL
clearly	NULL
showed	NULL
induced	NULL
ICAM-1	NULL
expression	NULL
.	NULL

levels	NULL
of	NULL
LMP1	NULL
expression	NULL
gave	NULL
a	NULL
punctate	NULL
staining	NULL
similar	NULL
to	NULL
that	NULL
generally	NULL
observed	NULL
for	NULL
normal	NULL
LMP1	NULL
expression	NULL
in	NULL
LCLs	NULL
.	NULL

It	NULL
was	NULL
noted	NULL
that	NULL
cells	NULL
which	NULL
showed	NULL
the	NULL
most	NULL
intense	NULL
overex-pression	NULL
of	NULL
LMP1	NULL
did	NULL
not	NULL
show	NULL
induction	NULL
of	NULL
ICAM-1	NULL
or	NULL
Bel-2	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

A	NULL
summary	NULL
of	NULL
the	NULL
data	NULL
obtained	NULL
with	NULL
a	NULL
wider	NULL
panel	NULL
of	NULL
lines	NULL
J.	NULL
ViroL	NULL
.	NULL

TABLE	NULL
1	NULL
.	NULL

Analysis	NULL
of	NULL
LMP1-mediated	NULL
induction	NULL
of	NULL
ICAM-1	NULL
and	NULL
Bcl-2	NULL
in	NULL
different	NULL
cell	NULL
lines	NULL
``	NULL
Percentage	NULL
of	NULL
cells	NULL
showing	NULL
j	NULL
8	NULL
%	NULL
of	NULL
Bel-2*	NULL
Cell	NULL
line	NULL
induced	NULL
expression	NULL
of	NULL
:	NULL
cells	NULL
in	NULL
LMP1*	NULL
LMP1	NULL
ICAM-1	NULL
Bel-2	NULL
population®	NULL
B	NULL
cell	NULL
DG75	NULL
16.5	NULL
72	NULL
4.0	NULL
24	NULL
BJAB	NULL
7.0	NULL
2.0	NULL
0.5	NULL
7	NULL
BL41	NULL
9.0	NULL
2.0	NULL
0.6	NULL
7	NULL
RAEL	NULL
5.9	NULL
4.1	NULL
1.9	NULL
32	NULL
ELI-BL	NULL
8.0	NULL
0.7	NULL
0.6	NULL
8	NULL
AKATA	NULL
10.0	NULL
0	NULL
0	NULL
0	NULL
T	NULL
cell	NULL
Jurkat	NULL
14.4	NULL
6.9	NULL
0	NULL
o	NULL
HPB-ALL	NULL
7.3	NULL
5.3	NULL
0	NULL
0	NULL
Erythroleukemic	NULL
K562	NULL
28.0	NULL
13.0	NULL
0	NULL
0	NULL
``	NULL
Cells	NULL
were	NULL
electroporated	NULL
with	NULL
DNA	NULL
containing	NULL
a	NULL
CMV	NULL
promoter-driven	NULL
LMP1	NULL
gene	NULL
,	NULL
and	NULL
expression	NULL
of	NULL
LMP1	NULL
,	NULL
ICAM-1	NULL
,	NULL
and	NULL
Bcl-2	NULL
was	NULL
analyzed	NULL
by	NULL
immunofluorescence	NULL
and	NULL
confocal	NULL
microscopy	NULL
of	NULL
cells	NULL
that	NULL
were	NULL
fixed	NULL
and	NULL
stained	NULL
at	NULL
72	NULL
h	NULL
posttransfection	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
and	NULL
6	NULL
.	NULL

®	NULL
Values	NULL
were	NULL
calculated	NULL
assuming	NULL
that	NULL
all	NULL
Bcl-2*	NULL
cells	NULL
were	NULL
LMP1*	NULL
,	NULL
as	NULL
illustrated	NULL
for	NULL
DG75	NULL
in	NULL
Fig	NULL
.	NULL

6.	NULL
is	NULL
given	NULL
in	NULL
Table	NULL
1	NULL
.	NULL

Importantly	NULL
,	NULL
induction	NULL
of	NULL
Bel-2	NULL
by	NULL
LMP1	NULL
was	NULL
observed	NULL
in	NULL
five	NULL
of	NULL
five	NULL
B-cell	NULL
lines	NULL
in	NULL
which	NULL
ICAM-1	NULL
was	NULL
also	NULL
upregulated	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Bel-2	NULL
was	NULL
not	NULL
induced	NULL
in	NULL
any	NULL
of	NULL
three	NULL
non-B-cell	NULL
lines	NULL
studied	NULL
,	NULL
even	NULL
though	NULL
ICAM-1	NULL
was	NULL
clearly	NULL
upregulated	NULL
by	NULL
LMP1	NULL
in	NULL
each	NULL
case	NULL
.	NULL

The	NULL
AKATA	NULL
BL	NULL
line	NULL
was	NULL
unusual	NULL
in	NULL
that	NULL
it	NULL
was	NULL
the	NULL
only	NULL
B-cell	NULL
line	NULL
studied	NULL
in	NULL
which	NULL
LMP1	NULL
did	NULL
not	NULL
effect	NULL
upregulation	NULL
of	NULL
ICAM-1	NULL
or	NULL
Bcl-2	NULL
.	NULL

The	NULL
cellular	NULL
localization	NULL
and	NULL
levels	NULL
of	NULL
LMP1	NULL
expression	NULL
in	NULL
the	NULL
transfected	NULL
AKATA	NULL
BL	NULL
cells	NULL
were	NULL
indistinguishable	NULL
from	NULL
those	NULL
observed	NULL
in	NULL
other	NULL
transfected	NULL
B-cell	NULL
lines	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
a	NULL
series	NULL
of	NULL
stable	NULL
clones	NULL
of	NULL
LMPI1I-transfected	NULL
AKATA	NULL
cells	NULL
was	NULL
also	NULL
found	NULL
not	NULL
to	NULL
have	NULL
induced	NULL
ICAM-1	NULL
or	NULL
Bcel-2	NULL
expression	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Table	NULL
1	NULL
also	NULL
show	NULL
that	NULL
the	NULL
percentage	NULL
of	NULL
cells	NULL
expressing	NULL
Bci-2	NULL
in	NULL
transfected	NULL
B-cell	NULL
lines	NULL
was	NULL
always	NULL
lower	NULL
than	NULL
the	NULL
percentage	NULL
of	NULL
cells	NULL
expressing	NULL
ICAM-1	NULL
at	NULL
72	NULL
h.	NULL
The	NULL
possibility	NULL
that	NULL
this	NULL
may	NULL
simply	NULL
reflect	NULL
different	NULL
kinetics	NULL
of	NULL
induction	NULL
for	NULL
the	NULL
two	NULL
cellular	NULL
proteins	NULL
was	NULL
suggested	NULL
from	NULL
the	NULL
results	NULL
of	NULL
earlier	NULL
experiments	NULL
with	NULL
cadmium-induced	NULL
MTLM	NULL
transfectants	NULL
of	NULL
ELI-BL	NULL
and	NULL
BL41	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

This	NULL
interpretation	NULL
was	NULL
tested	NULL
by	NULL
analyzing	NULL
electroporated	NULL
DG75	NULL
cells	NULL
over	NULL
a	NULL
3-day	NULL
period	NULL
.	NULL

Figure	NULL
7	NULL
shows	NULL
that	NULL
the	NULL
percentage	NULL
of	NULL
LMP1-positive	NULL
DG75	NULL
cells	NULL
was	NULL
in	NULL
excess	NULL
of	NULL
50	NULL
%	NULL
at	NULL
18	NULL
h	NULL
but	NULL
dropped	NULL
sharply	NULL
to	NULL
around	NULL
20	NULL
%	NULL
by	NULL
48	NULL
h	NULL
;	NULL
it	NULL
was	NULL
also	NULL
observed	NULL
that	NULL
the	NULL
intensity	NULL
of	NULL
LMP1	NULL
staining	NULL
was	NULL
reduced	NULL
with	NULL
time	NULL
so	NULL
that	NULL
by	NULL
72	NULL
h	NULL
most	NULL
of	NULL
the	NULL
LMP1-positive	NULL
cells	NULL
showed	NULL
staining	NULL
comparable	NULL
to	NULL
that	NULL
seen	NULL
in	NULL
normal	NULL
EBV-transformed	NULL
LCLs	NULL
.	NULL

Whilst	NULL
ICAM-1-positive	NULL
cells	NULL
were	NULL
apparent	NULL
at	NULL
18	NULL
h	NULL
postelectroporation	NULL
,	NULL
the	NULL
maximum	NULL
percentage	NULL
of	NULL
positive	NULL
cells	NULL
was	NULL
observed	NULL
at	NULL
around	NULL
48	NULL
h	NULL
,	NULL
and	NULL
by	NULL
72	NULL
h	NULL
the	NULL
percentage	NULL
of	NULL
ICAM-1-positive	NULL
cells	NULL
had	NULL
decreased	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
induction	NULL
of	NULL
Bcel-2-positive	NULL
cells	NULL
was	NULL
not	NULL
observed	NULL
until	NULL
48	NULL
h	NULL
postelectroporation	NULL
,	NULL
and	NULL
the	NULL
percentage	NULL
of	NULL
Bel-2-positive	NULL
cells	NULL
continued	NULL
to	NULL
rise	NULL
between	NULL
48	NULL
and	NULL
72	NULL
h.	NULL
Taken	NULL
together	NULL
,	NULL
the	NULL
data	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
2	NULL
,	NULL
3	NULL
,	NULL
and	NULL
7	NULL
suggest	NULL
that	NULL
the	NULL
induction	NULL
of	NULL
Bcl-2	NULL
expression	NULL
by	NULL
LMP1	NULL
lags	NULL
behind	NULL
the	NULL
induction	NULL
of	NULL
ICAM-1	NULL
by	NULL
about	NULL
24	NULL
h.	NULL
NF-KB	NULL
is	NULL
activated	NULL
by	NULL
LMP1	NULL
both	NULL
in	NULL
B-cell	NULL
and	NULL
in	NULL
non-B-cell	NULL
lines	NULL
.	NULL

Having	NULL
demonstrated	NULL
that	NULL
the	NULL
kB.CONA.LUC	NULL
reporter	NULL
could	NULL
be	NULL
used	NULL
to	NULL
investigate	NULL
LMP1-mediated	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
,	NULL
we	NULL
then	NULL
used	NULL
a	NULL
transient	NULL
cotransfection	NULL
protocol	NULL
to	NULL
investigate	NULL
LMP	NULL
1-mediated	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
Vor	NULL
.	NULL

68	NULL
,	NULL
1994	NULL
A	NULL
B	NULL
C	NULL
60	NULL
20	NULL
10	NULL
LMP1	NULL
ICAM-1	NULL
Bct-2	NULL
e	NULL
57	NULL
=	NULL
157	NULL
lll	NULL
&	NULL
401	NULL
a	NULL
8	NULL
307	NULL
107	NULL
57	NULL
©	NULL
t	NULL
§	NULL
``	NULL
I	NULL
5	NULL
51	NULL
a	NULL
.	NULL

101	NULL
07	NULL
07	NULL
07	NULL
0	NULL
18	NULL
48	NULL
72	NULL
0	NULL
18	NULL
48	NULL
72	NULL
0	NULL
18	NULL
48	NULL
72	NULL
Time	NULL
(	NULL
hours	NULL
)	NULL
post-electroporation	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Kinetics	NULL
of	NULL
transient	NULL
LMP	NULL
1	NULL
,	NULL
ICAM-1	NULL
,	NULL
and	NULL
Bel-2	NULL
expression	NULL
in	NULL
DG75	NULL
cells	NULL
transfected	NULL
with	NULL
DNA	NULL
containing	NULL
a	NULL
CMV-driven	NULL
LMP1	NULL
gene	NULL
.	NULL

Cells	NULL
harvested	NULL
at	NULL
18	NULL
,	NULL
48	NULL
,	NULL
and	NULL
72	NULL
h	NULL
were	NULL
fixed	NULL
,	NULL
stained	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
confocal	NULL
microscopy	NULL
as	NULL
for	NULL
Fig	NULL
.	NULL

5.	NULL
the	NULL
wider	NULL
panel	NULL
of	NULL
lines	NULL
.	NULL

A	NULL
plasmid	NULL
containing	NULL
the	NULL
hGH	NULL
gene	NULL
expressed	NULL
from	NULL
a	NULL
constitutively	NULL
active	NULL
strong	NULL
promoter	NULL
(	NULL
pCMV.LTR.GH	NULL
)	NULL
was	NULL
included	NULL
in	NULL
every	NULL
cotransfection	NULL
so	NULL
that	NULL
the	NULL
hGH	NULL
secreted	NULL
into	NULL
the	NULL
culture	NULL
supernatant	NULL
could	NULL
be	NULL
assayed	NULL
and	NULL
used	NULL
to	NULL
monitor	NULL
,	NULL
and	NULL
correct	NULL
for	NULL
,	NULL
transfection	NULL
efficiency	NULL
.	NULL

Because	NULL
the	NULL
secreted	NULL
hGH	NULL
has	NULL
to	NULL
accumulate	NULL
sufficiently	NULL
before	NULL
it	NULL
can	NULL
be	NULL
detected	NULL
by	NULL
ELISA	NULL
,	NULL
the	NULL
hGH	NULL
and	NULL
luciferase	NULL
assays	NULL
were	NULL
both	NULL
performed	NULL
at	NULL
24	NULL
h	NULL
posttransfection	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
activities	NULL
were	NULL
determined	NULL
as	NULL
arbitary	NULL
units	NULL
of	NULL
luciferase	NULL
activity	NULL
,	NULL
corrected	NULL
for	NULL
transfection	NULL
efficiency	NULL
with	NULL
the	NULL
hGH	NULL
data	NULL
,	NULL
and	NULL
normalized	NULL
to	NULL
the	NULL
luciferase	NULL
activity	NULL
of	NULL
the	NULL
transfected	NULL
RAEL	NULL
line	NULL
which	NULL
was	NULL
included	NULL
in	NULL
every	NULL
assay	NULL
and	NULL
was	NULL
assigned	NULL
an	NULL
activity	NULL
of	NULL
1	NULL
U	NULL
.	NULL

First	NULL
,	NULL
in	NULL
order	NULL
to	NULL
verify	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
activated	NULL
by	NULL
EBV	NULL
,	NULL
two	NULL
phenotypically	NULL
distinct	NULL
subclones	NULL
of	NULL
the	NULL
EBV-positive	NULL
BL	NULL
line	NULL
MUTU	NULL
(	NULL
16	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
reporter	NULL
plasmids	NULL
.	NULL

The	NULL
relative	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
of	NULL
the	NULL
group	NULL
I	NULL
subline	NULL
(	NULL
expressing	NULL
only	NULL
EBNA1	NULL
)	NULL
was	NULL
measured	NULL
as	NULL
0.2	NULL
U	NULL
whilst	NULL
the	NULL
relative	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
of	NULL
the	NULL
group	NULL
III	NULL
subline	NULL
(	NULL
expressing	NULL
LMP1	NULL
,	NULL
LMP2	NULL
,	NULL
and	NULL
all	NULL
six	NULL
EB-NAs	NULL
)	NULL
was	NULL
measured	NULL
as	NULL
3.3	NULL
U	NULL
.	NULL

Table	NULL
2	NULL
shows	NULL
the	NULL
relative	NULL
NF-kB	NULL
activities	NULL
of	NULL
several	NULL
cell	NULL
lines	NULL
into	NULL
which	NULL
the	NULL
two	NULL
reporter	NULL
constructs	NULL
were	NULL
cotransfected	NULL
INDUCTION	NULL
OF	NULL
Bel-2	NULL
BY	NULL
LMPI	NULL
5609	NULL
either	NULL
with	NULL
pCMVLMP1	NULL
or	NULL
with	NULL
the	NULL
corresponding	NULL
control	NULL
plasmid	NULL
.	NULL

These	NULL
data	NULL
demonstrate	NULL
that	NULL
activation	NULL
of	NULL
NF-kB	NULL
by	NULL
LMP1	NULL
occurs	NULL
in	NULL
all	NULL
cell	NULL
types	NULL
studied	NULL
,	NULL
including	NULL
B	NULL
cells	NULL
,	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
proerythromyelocytic	NULL
cells	NULL
Of	NULL
the	NULL
B-cell	NULL
lines	NULL
,	NULL
DG75	NULL
showed	NULL
only	NULL
poor	NULL
induction	NULL
of	NULL
NF-kB	NULL
activity	NULL
following	NULL
transient	NULL
expression	NULL
of	NULL
LMP1	NULL
,	NULL
but	NULL
this	NULL
cell	NULL
line	NULL
was	NULL
unusual	NULL
amongst	NULL
the	NULL
BL	NULL
lines	NULL
in	NULL
having	NULL
a	NULL
high	NULL
basal	NULL
NF-kB	NULL
activity	NULL
,	NULL
which	NULL
was	NULL
comparable	NULL
to	NULL
that	NULL
observed	NULL
in	NULL
the	NULL
group	NULL
III	NULL
subclone	NULL
of	NULL
MUTU-BL	NULL
which	NULL
expressed	NULL
LMP1	NULL
along	NULL
with	NULL
all	NULL
the	NULL
other	NULL
EBV	NULL
latent	NULL
genes	NULL
(	NULL
see	NULL
above	NULL
)	NULL
.	NULL

This	NULL
higher	NULL
basal	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
in	NULL
DG75	NULL
may	NULL
be	NULL
relevant	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
higher	NULL
basal	NULL
levels	NULL
of	NULL
ICAM-1	NULL
observed	NULL
on	NULL
DG75	NULL
cells	NULL
compared	NULL
with	NULL
the	NULL
other	NULL
BL	NULL
lines	NULL
studied	NULL
.	NULL

Finally	NULL
,	NULL
it	NULL
was	NULL
interesting	NULL
to	NULL
note	NULL
that	NULL
the	NULL
AKATA	NULL
BL	NULL
line	NULL
,	NULL
which	NULL
was	NULL
unresponsive	NULL
to	NULL
LMP1	NULL
with	NULL
respect	NULL
to	NULL
changes	NULL
in	NULL
cellular	NULL
phenotype	NULL
,	NULL
did	NULL
show	NULL
a	NULL
significant	NULL
increase	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
following	NULL
expression	NULL
of	NULL
LMP1	NULL
.	NULL

DISCUSSION	NULL
Our	NULL
original	NULL
suggestion	NULL
that	NULL
LMPI	NULL
expression	NULL
in	NULL
B	NULL
cells	NULL
leads	NULL
to	NULL
upregulation	NULL
of	NULL
Bel-2	NULL
was	NULL
based	NULL
on	NULL
results	NULL
obtained	NULL
with	NULL
stable	NULL
drug-selected	NULL
clones	NULL
of	NULL
LMPI1	NULL
gene-transfected	NULL
cells	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Another	NULL
possible	NULL
interpretation	NULL
of	NULL
our	NULL
results	NULL
was	NULL
recently	NULL
proposed	NULL
by	NULL
Martin	NULL
et	NULL
al	NULL
.	NULL

(	NULL
35	NULL
)	NULL
,	NULL
who	NULL
argued	NULL
that	NULL
,	NULL
because	NULL
LMP1	NULL
is	NULL
toxic	NULL
when	NULL
overexpressed	NULL
in	NULL
certain	NULL
cells	NULL
,	NULL
the	NULL
only	NULL
clones	NULL
able	NULL
to	NULL
tolerate	NULL
stable	NULL
LMP	NULL
1	NULL
expression	NULL
would	NULL
be	NULL
those	NULL
which	NULL
had	NULL
been	NULL
protected	NULL
from	NULL
LMPI1	NULL
toxicity	NULL
by	NULL
spontaneous	NULL
upregulation	NULL
of	NULL
Bel-2	NULL
.	NULL

The	NULL
results	NULL
of	NULL
our	NULL
present	NULL
study	NULL
do	NULL
not	NULL
support	NULL
this	NULL
alternative	NULL
interpretation	NULL
but	NULL
are	NULL
instead	NULL
consistent	NULL
with	NULL
our	NULL
original	NULL
conclusion	NULL
that	NULL
LMP1	NULL
specifically	NULL
upregulates	NULL
Bcl-2	NULL
in	NULL
B	NULL
lymphocytes	NULL
.	NULL

Potential	NULL
biases	NULL
inherent	NULL
in	NULL
selecting	NULL
stable	NULL
LMP	NULL
1-express-ing	NULL
clones	NULL
were	NULL
eliminated	NULL
in	NULL
our	NULL
present	NULL
study	NULL
by	NULL
analyzing	NULL
expression	NULL
of	NULL
Bcl-2	NULL
during	NULL
a	NULL
72-h	NULL
period	NULL
after	NULL
expressing	NULL
LMP1	NULL
.	NULL

In	NULL
one	NULL
experimental	NULL
approach	NULL
,	NULL
Bel-2	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
upregulated	NULL
in	NULL
two	NULL
B-cell	NULL
lines	NULL
within	NULL
48	NULL
to	NULL
72	NULL
h	NULL
of	NULL
inducing	NULL
LMP1	NULL
expression	NULL
from	NULL
a	NULL
cadmium-inducible	NULL
metallothionein	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

This	NULL
result	NULL
was	NULL
particularly	NULL
informative	NULL
because	NULL
(	NULL
i	NULL
)	NULL
there	NULL
was	NULL
no	NULL
suggestion	NULL
of	NULL
any	NULL
LMP	NULL
1-induced	NULL
toxicity	NULL
within	NULL
the	NULL
time	NULL
course	NULL
of	NULL
the	NULL
experiment	NULL
,	NULL
(	NULL
ii	NULL
)	NULL
LMPI	NULL
was	NULL
induced	NULL
in	NULL
all	NULL
cells	NULL
of	NULL
the	NULL
cadmium-treated	NULL
culture	NULL
,	NULL
and	NULL
TABLE	NULL
2	NULL
.	NULL

LMP1-mediated	NULL
induction	NULL
of	NULL
ICAM-1	NULL
,	NULL
Bel-2	NULL
,	NULL
and	NULL
NF-xB	NULL
activity	NULL
in	NULL
different	NULL
cell	NULL
lines	NULL
Induction	NULL
of	NULL
cellular	NULL
proteins	NULL
by	NULL
LMPI	NULL
``	NULL
NF-kB	NULL
activity	NULL
(	NULL
luciferase	NULL
units	NULL
)	NULL
``	NULL
Cell	NULL
line	NULL
P	NULL
t	NULL
4	NULL
ICAM-1	NULL
Bcl-2	NULL
Control	NULL
transfection	NULL
LMP1	NULL
transfection	NULL
Stimulation	NULL
index	NULL
B	NULL
cell	NULL
DG75	NULL
+	NULL
+	NULL
3.0	NULL
4.2	NULL
1.5	NULL
*	NULL
0.6	NULL
(	NULL
5	NULL
)	NULL
BJAB	NULL
+	NULL
+	NULL
0.53	NULL
1.0	NULL
1.9	NULL
+	NULL
0.3	NULL
(	NULL
3	NULL
)	NULL
BL41	NULL
+	NULL
+	NULL
0.10	NULL
0.65	NULL
6.4	NULL
(	NULL
1	NULL
)	NULL
RAEL	NULL
+	NULL
+	NULL
1.0	NULL
4.5	NULL
4.5	NULL
+	NULL
3.1	NULL
(	NULL
7	NULL
)	NULL
ELI-BL	NULL
+	NULL
+	NULL
0.63	NULL
1.9	NULL
4.3	NULL
+	NULL
3.7	NULL
(	NULL
3	NULL
)	NULL
AKATA	NULL
~-	NULL
-	NULL
0.62	NULL
1.3	NULL
24	NULL
+	NULL
1.0	NULL
(	NULL
3	NULL
)	NULL
T	NULL
cell	NULL
Jurkat	NULL
+	NULL
-	NULL
0.08	NULL
0.82	NULL
11.2	NULL
*	NULL
3.7	NULL
(	NULL
4	NULL
)	NULL
HPB-ALL	NULL
+	NULL
-	NULL
0.50	NULL
2.0	NULL
4.3	NULL
*	NULL
1.4	NULL
(	NULL
4	NULL
)	NULL
Erythroleukemic	NULL
K562	NULL
+	NULL
-	NULL
1.3	NULL
12.4	NULL
14.2	NULL
*+	NULL
8.7	NULL
(	NULL
6	NULL
)	NULL
``	NULL
Induction	NULL
of	NULL
ICAM-1	NULL
and	NULL
Bcl-2	NULL
was	NULL
measured	NULL
at	NULL
72	NULL
h	NULL
after	NULL
transfection	NULL
with	NULL
the	NULL
LMP	NULL
]	NULL
gene	NULL
as	NULL
in	NULL
Table	NULL
1	NULL
.	NULL

``	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
was	NULL
determined	NULL
by	NULL
measuring	NULL
luciferase	NULL
activity	NULL
in	NULL
cells	NULL
at	NULL
24	NULL
h	NULL
following	NULL
cotransfection	NULL
with	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
luciferase	NULL
reporter	NULL
(	NULL
kB.CONA.LUC	NULL
)	NULL
.	NULL

A	NULL
plasmid	NULL
constitutively	NULL
expressing	NULL
hGH	NULL
(	NULL
pCMV.LTR.GH	NULL
)	NULL
was	NULL
used	NULL
to	NULL
correct	NULL
for	NULL
variations	NULL
in	NULL
transfection	NULL
efficiency	NULL
.	NULL

The	NULL
data	NULL
are	NULL
pooled	NULL
from	NULL
seven	NULL
separate	NULL
experiments	NULL
.	NULL

The	NULL
RAEL	NULL
BL	NULL
line	NULL
,	NULL
which	NULL
was	NULL
included	NULL
in	NULL
every	NULL
experiment	NULL
as	NULL
a	NULL
reference	NULL
line	NULL
,	NULL
was	NULL
given	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
of	NULL
1	NULL
arbitary	NULL
unit	NULL
.	NULL

©	NULL
The	NULL
stimulation	NULL
index	NULL
represents	NULL
the	NULL
ratio	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
of	NULL
the	NULL
LMP	NULL
1-transfected	NULL
cultures	NULL
to	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
of	NULL
the	NULL
control-transfected	NULL
cultures	NULL
.	NULL

Ratios	NULL
were	NULL
determined	NULL
from	NULL
each	NULL
experiment	NULL
,	NULL
and	NULL
the	NULL
mean	NULL
value	NULL
*	NULL
standard	NULL
deviation	NULL
was	NULL
determined	NULL
for	NULL
the	NULL
number	NULL
of	NULL
experiments	NULL
indicated	NULL
in	NULL
parentheses	NULL
.	NULL

5610	NULL
ROWE	NULL
ET	NULL
AL	NULL
.	NULL

(	NULL
ifi	NULL
)	NULL
immunofluorescence	NULL
staining	NULL
indicated	NULL
that	NULL
Bcl-2	NULL
upregulation	NULL
occurred	NULL
in	NULL
the	NULL
majority	NULL
of	NULL
cells	NULL
and	NULL
was	NULL
not	NULL
confined	NULL
to	NULL
a	NULL
small	NULL
subpopulation	NULL
.	NULL

A	NULL
second	NULL
experimental	NULL
approach	NULL
,	NULL
which	NULL
entailed	NULL
transient	NULL
expression	NULL
of	NULL
a	NULL
transfected	NULL
LMP1	NULL
gene	NULL
driven	NULL
by	NULL
a	NULL
constitutively	NULL
active	NULL
promoter	NULL
in	NULL
a	NULL
subpopulation	NULL
of	NULL
cells	NULL
,	NULL
likewise	NULL
demonstrated	NULL
upregulation	NULL
of	NULL
Bcel-2	NULL
in	NULL
five	NULL
B-cell	NULL
lines	NULL
which	NULL
also	NULL
responded	NULL
to	NULL
LMP1	NULL
by	NULL
upregulating	NULL
ICAM-1	NULL
expression	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
Bel-2	NULL
upregulation	NULL
were	NULL
similar	NULL
in	NULL
both	NULL
sets	NULL
of	NULL
experiments	NULL
and	NULL
showed	NULL
that	NULL
upregulation	NULL
of	NULL
Bel-2	NULL
is	NULL
a	NULL
relatively	NULL
late	NULL
feature	NULL
of	NULL
the	NULL
LMP1-induced	NULL
phenotype	NULL
,	NULL
always	NULL
lagging	NULL
behind	NULL
the	NULL
upregulation	NULL
of	NULL
ICAM-1	NULL
and	NULL
sometimes	NULL
not	NULL
detectable	NULL
until	NULL
72	NULL
h.	NULL
This	NULL
observation	NULL
offers	NULL
an	NULL
explanation	NULL
as	NULL
to	NULL
why	NULL
detection	NULL
of	NULL
Bcl-2	NULL
upregulation	NULL
has	NULL
previously	NULL
been	NULL
difficult	NULL
in	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
LMP1	NULL
gene	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
found	NULL
that	NULL
gross	NULL
overexpres-sion	NULL
of	NULL
LMP1	NULL
was	NULL
not	NULL
conducive	NULL
to	NULL
upregulation	NULL
of	NULL
ICAM-1	NULL
or	NULL
of	NULL
Bel-2	NULL
(	NULL
indeed	NULL
,	NULL
these	NULL
cells	NULL
probably	NULL
die	NULL
)	NULL
.	NULL

Instead	NULL
,	NULL
upregulation	NULL
of	NULL
Bel-2	NULL
occurred	NULL
in	NULL
cells	NULL
expressing	NULL
levels	NULL
of	NULL
LMP1	NULL
more	NULL
typical	NULL
of	NULL
that	NULL
in	NULL
LCLs	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Consequently	NULL
,	NULL
in	NULL
transient	NULL
expression	NULL
experiments	NULL
in	NULL
which	NULL
the	NULL
LMP1	NULL
gene	NULL
is	NULL
driven	NULL
by	NULL
the	NULL
strong	NULL
CMV	NULL
promoter	NULL
,	NULL
not	NULL
all	NULL
the	NULL
LMP1-positive	NULL
cells	NULL
show	NULL
induction	NULL
of	NULL
Bel-2	NULL
or	NULL
of	NULL
ICAM-1	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
and	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Given	NULL
the	NULL
low	NULL
transfection	NULL
efficiency	NULL
of	NULL
some	NULL
cell	NULL
lines	NULL
,	NULL
this	NULL
means	NULL
that	NULL
Bcl-2	NULL
upregulation	NULL
may	NULL
occur	NULL
in	NULL
fewer	NULL
than	NULL
1	NULL
%	NULL
of	NULL
the	NULL
total	NULL
viable	NULL
cell	NULL
population	NULL
;	NULL
detection	NULL
of	NULL
this	NULL
effect	NULL
requires	NULL
an	NULL
analytical	NULL
procedure	NULL
with	NULL
appropriate	NULL
sensitivity	NULL
,	NULL
such	NULL
as	NULL
immunofluorescence	NULL
and	NULL
confocal	NULL
microscopy	NULL
.	NULL

The	NULL
data	NULL
obtained	NULL
in	NULL
the	NULL
present	NULL
study	NULL
suggest	NULL
that	NULL
the	NULL
ability	NULL
of	NULL
LMP1	NULL
to	NULL
upregulate	NULL
Bel-2	NULL
may	NULL
be	NULL
restricted	NULL
to	NULL
target	NULL
cells	NULL
of	NULL
the	NULL
B-cell	NULL
lineage	NULL
.	NULL

Thus	NULL
,	NULL
upregulation	NULL
of	NULL
Bcl-2	NULL
was	NULL
never	NULL
observed	NULL
in	NULL
either	NULL
of	NULL
two	NULL
T-lymphoblastoid	NULL
lines	NULL
or	NULL
in	NULL
the	NULL
K562	NULL
proerythromyelocytic	NULL
cell	NULL
line	NULL
following	NULL
electroporation	NULL
of	NULL
the	NULL
pCMVLMP1	NULL
plasmid	NULL
and	NULL
transient	NULL
expression	NULL
of	NULL
LMP1	NULL
(	NULL
Tables	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

Other	NULL
unpublished	NULL
data	NULL
from	NULL
our	NULL
laboratory	NULL
show	NULL
that	NULL
LMP1	NULL
also	NULL
does	NULL
not	NULL
upregulate	NULL
Bel-2	NULL
in	NULL
a	NULL
human	NULL
epithelial	NULL
cell	NULL
line	NULL
(	NULL
7a	NULL
)	NULL
.	NULL

These	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
results	NULL
of	NULL
Martin	NULL
et	NULL
al	NULL
.	NULL

(	NULL
35	NULL
)	NULL
,	NULL
who	NULL
showed	NULL
that	NULL
LMP	NULL
1	NULL
causes	NULL
upregulation	NULL
of	NULL
Bcl-2	NULL
in	NULL
the	NULL
B-lymphoma	NULL
line	NULL
BJAB	NULL
but	NULL
is	NULL
unable	NULL
to	NULL
induce	NULL
Bcl-2	NULL
in	NULL
BALB/c	NULL
3T3	NULL
fibroblasts	NULL
.	NULL

The	NULL
apparent	NULL
B-cell	NULL
lineage-restricted	NULL
upregulation	NULL
of	NULL
Bcl-2	NULL
by	NULL
LMP1	NULL
contrasts	NULL
with	NULL
the	NULL
upregulation	NULL
of	NULL
ICAM-1	NULL
which	NULL
is	NULL
observed	NULL
both	NULL
in	NULL
B-cell	NULL
lines	NULL
and	NULL
in	NULL
a	NULL
number	NULL
of	NULL
non-B-cell	NULL
types	NULL
,	NULL
including	NULL
T	NULL
cells	NULL
and	NULL
proerythromyelocytes	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
,	NULL
and	NULL
in	NULL
epithelial	NULL
cells	NULL
(	NULL
8	NULL
)	NULL
.	NULL

It	NULL
is	NULL
worth	NULL
noting	NULL
that	NULL
human	NULL
T	NULL
cells	NULL
and	NULL
epithelial	NULL
cells	NULL
can	NULL
under	NULL
certain	NULL
circumstances	NULL
express	NULL
Bel-2	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
22	NULL
)	NULL
and	NULL
that	NULL
the	NULL
inability	NULL
of	NULL
LMP1	NULL
to	NULL
upregulate	NULL
the	NULL
cellular	NULL
oncogene	NULL
in	NULL
these	NULL
cell	NULL
types	NULL
does	NULL
not	NULL
therefore	NULL
reflect	NULL
an	NULL
inherent	NULL
inability	NULL
to	NULL
express	NULL
Bcl-2	NULL
.	NULL

Our	NULL
conclusion	NULL
from	NULL
the	NULL
above	NULL
transfection	NULL
experiments	NULL
is	NULL
that	NULL
Bcl-2	NULL
upregulation	NULL
does	NULL
indeed	NULL
represent	NULL
one	NULL
of	NULL
a	NULL
series	NULL
of	NULL
downstream	NULL
events	NULL
mediated	NULL
by	NULL
LMP1	NULL
expression	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Besides	NULL
the	NULL
importance	NULL
of	NULL
this	NULL
to	NULL
the	NULL
overall	NULL
biology	NULL
of	NULL
EBV	NULL
infections	NULL
in	NULL
the	NULL
B-lymphoid	NULL
system	NULL
,	NULL
Bcl-2	NULL
upregulation	NULL
also	NULL
provides	NULL
an	NULL
in	NULL
vitro	NULL
readout	NULL
of	NULL
LMP1	NULL
function	NULL
which	NULL
,	NULL
in	NULL
terms	NULL
both	NULL
of	NULL
cell	NULL
lineage	NULL
restriction	NULL
and	NULL
of	NULL
kinetics	NULL
,	NULL
is	NULL
distinct	NULL
from	NULL
the	NULL
effect	NULL
of	NULL
LMP1	NULL
upon	NULL
cell	NULL
surface	NULL
markers	NULL
such	NULL
as	NULL
ICAM-1	NULL
and	NULL
LFA-3	NULL
.	NULL

In	NULL
the	NULL
longer	NULL
term	NULL
,	NULL
therefore	NULL
,	NULL
the	NULL
Bcl-2	NULL
effect	NULL
may	NULL
prove	NULL
important	NULL
in	NULL
elucidating	NULL
the	NULL
nature	NULL
of	NULL
LMP1	NULL
cell	NULL
signalling	NULL
pathways	NULL
.	NULL

In	NULL
this	NULL
latter	NULL
context	NULL
,	NULL
others	NULL
have	NULL
shown	NULL
that	NULL
one	NULL
early	NULL
effect	NULL
of	NULL
LMP1	NULL
expression	NULL
is	NULL
to	NULL
activate	NULL
NF-kB	NULL
(	NULL
18	NULL
,	NULL
26	NULL
)	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
that	NULL
is	NULL
a	NULL
pleiotropic	NULL
mediator	NULL
of	NULL
inducible	NULL
gene	NULL
control	NULL
(	NULL
17	NULL
,	NULL
27	NULL
)	NULL
.	NULL

Inactive	NULL
NF-	NULL
«	NULL
B	NULL
heterodimers	NULL
are	NULL
stored	NULL
in	NULL
the	NULL
cytoplasm	NULL
,	NULL
and	NULL
activation	NULL
involves	NULL
release	NULL
of	NULL
these	NULL
dimers	NULL
from	NULL
an	NULL
inhibitory	NULL
protein	NULL
,	NULL
IxB	NULL
,	NULL
which	NULL
triggers	NULL
translocation	NULL
of	NULL
active	NULL
NF-	NULL
«	NULL
B	NULL
dimers	NULL
to	NULL
the	NULL
nucleus	NULL
where	NULL
they	NULL
effect	NULL
their	NULL
J.	NULL
ViroL	NULL
.	NULL

function	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Various	NULL
members	NULL
of	NULL
the	NULL
adhesion	NULL
molecule	NULL
family	NULL
,	NULL
including	NULL
ICAM-1	NULL
(	NULL
7	NULL
,	NULL
52	NULL
)	NULL
,	NULL
have	NULL
NF-	NULL
«	NULL
B-responsive	NULL
elements	NULL
proximal	NULL
to	NULL
their	NULL
gene	NULL
promoters	NULL
.	NULL

This	NULL
lends	NULL
credibility	NULL
to	NULL
the	NULL
hypothesis	NULL
that	NULL
LMP1	NULL
upregulates	NULL
the	NULL
adhesion	NULL
molecules	NULL
through	NULL
activation	NULL
of	NULL
NF-kB	NULL
.	NULL

We	NULL
therefore	NULL
investigated	NULL
whether	NULL
LMP1-mediated	NULL
activation	NULL
of	NULL
NF-xB	NULL
was	NULL
cell	NULL
type	NULL
specific	NULL
,	NULL
possibly	NULL
correlating	NULL
with	NULL
induction	NULL
of	NULL
Bel-2	NULL
,	NULL
or	NULL
whether	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
was	NULL
observed	NULL
in	NULL
different	NULL
cellular	NULL
backgrounds	NULL
and	NULL
perhaps	NULL
correlated	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
ICAM-1	NULL
.	NULL

The	NULL
results	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
were	NULL
consistent	NULL
with	NULL
the	NULL
latter	NULL
scenario	NULL
.	NULL

It	NULL
is	NULL
important	NULL
,	NULL
however	NULL
,	NULL
to	NULL
recognize	NULL
that	NULL
regulation	NULL
of	NULL
gene	NULL
expression	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
complex	NULL
.	NULL

At	NULL
one	NULL
level	NULL
,	NULL
this	NULL
is	NULL
due	NULL
to	NULL
the	NULL
fact	NULL
that	NULL
there	NULL
are	NULL
at	NULL
least	NULL
five	NULL
different	NULL
proteins	NULL
that	NULL
can	NULL
form	NULL
dimers	NULL
that	NULL
bind	NULL
DNA	NULL
at	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
,	NULL
and	NULL
particular	NULL
combinations	NULL
of	NULL
protein	NULL
subunits	NULL
determine	NULL
the	NULL
specificity	NULL
of	NULL
transcriptional	NULL
activation	NULL
(	NULL
17	NULL
,	NULL
41	NULL
,	NULL
43	NULL
)	NULL
.	NULL

At	NULL
another	NULL
level	NULL
,	NULL
complexity	NULL
is	NULL
due	NULL
to	NULL
the	NULL
requirement	NULL
for	NULL
accessory	NULL
transcription	NULL
factors	NULL
that	NULL
may	NULL
regulate	NULL
binding	NULL
of	NULL
NF-kB	NULL
or	NULL
synergize	NULL
with	NULL
NF-KB	NULL
.	NULL

Thus	NULL
,	NULL
whilst	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
may	NULL
be	NULL
an	NULL
essential	NULL
feature	NULL
of	NULL
LMP1	NULL
signalling	NULL
,	NULL
its	NULL
activity	NULL
may	NULL
be	NULL
regulated	NULL
by	NULL
other	NULL
transacting	NULL
factors	NULL
and	NULL
cis-elements	NULL
(	NULL
18	NULL
,	NULL
21	NULL
,	NULL
41	NULL
)	NULL
.	NULL

Two	NULL
pieces	NULL
of	NULL
evidence	NULL
from	NULL
the	NULL
present	NULL
work	NULL
suggest	NULL
that	NULL
this	NULL
is	NULL
indeed	NULL
the	NULL
case	NULL
:	NULL
(	NULL
i	NULL
)	NULL
the	NULL
AKATA	NULL
BL	NULL
line	NULL
was	NULL
unusual	NULL
in	NULL
that	NULL
LMP1	NULL
did	NULL
not	NULL
upregulate	NULL
expression	NULL
of	NULL
ICAM-1	NULL
or	NULL
Bcl-2	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
and	NULL
yet	NULL
LMP1	NULL
did	NULL
activate	NULL
NF-kB	NULL
in	NULL
this	NULL
line	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
,	NULL
and	NULL
(	NULL
ii	NULL
)	NULL
the	NULL
DG75	NULL
BL	NULL
line	NULL
showed	NULL
a	NULL
high	NULL
basal	NULL
NF-kB	NULL
activity	NULL
that	NULL
was	NULL
comparable	NULL
to	NULL
that	NULL
measured	NULL
in	NULL
a	NULL
group	NULL
III	NULL
subclone	NULL
of	NULL
MUTU	NULL
BL	NULL
(	NULL
which	NULL
expresses	NULL
LMP1	NULL
,	NULL
LMP2	NULL
,	NULL
and	NULL
all	NULL
six	NULL
EB-NAs	NULL
)	NULL
,	NULL
and	NULL
whilst	NULL
LMP1	NULL
induced	NULL
a	NULL
barely	NULL
significant	NULL
increase	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
in	NULL
this	NULL
line	NULL
,	NULL
it	NULL
clearly	NULL
upregulated	NULL
both	NULL
ICAM-1	NULL
and	NULL
Bcl-2	NULL
.	NULL

Whilst	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
LMP1	NULL
upregulates	NULL
ICAM-1	NULL
via	NULL
NF-xB	NULL
,	NULL
albeit	NULL
in	NULL
synergy	NULL
with	NULL
other	NULL
inducible	NULL
transcription	NULL
factors	NULL
,	NULL
the	NULL
contribution	NULL
of	NULL
NF-KB	NULL
activation	NULL
to	NULL
Bel-2	NULL
upregulation	NULL
can	NULL
not	NULL
be	NULL
ascertained	NULL
at	NULL
present	NULL
because	NULL
the	NULL
regulatory	NULL
region	NULL
of	NULL
the	NULL
bel-2	NULL
gene	NULL
remains	NULL
to	NULL
be	NULL
identified	NULL
.	NULL

However	NULL
,	NULL
any	NULL
effect	NULL
of	NULL
NF-kB	NULL
upon	NULL
Bcl-2	NULL
expression	NULL
may	NULL
well	NULL
be	NULL
indirect	NULL
since	NULL
LMP	NULL
1-mediated	NULL
upregulation	NULL
of	NULL
Bel-2	NULL
always	NULL
lags	NULL
behind	NULL
the	NULL
upregulation	NULL
of	NULL
ICAM-1	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
7	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
it	NULL
remains	NULL
to	NULL
be	NULL
considered	NULL
what	NULL
is	NULL
the	NULL
biological	NULL
significance	NULL
of	NULL
LMP1-mediated	NULL
upregulation	NULL
of	NULL
Bcl-2	NULL
.	NULL

The	NULL
transformation	NULL
of	NULL
rodent	NULL
fibroblasts	NULL
by	NULL
LMP1	NULL
in	NULL
vitro	NULL
clearly	NULL
does	NULL
not	NULL
require	NULL
upregulation	NULL
of	NULL
Bcl-2	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
phenotypic	NULL
changes	NULL
induced	NULL
by	NULL
LMP1	NULL
in	NULL
human	NULL
epithelial	NULL
cells	NULL
(	NULL
8	NULL
,	NULL
11	NULL
)	NULL
also	NULL
do	NULL
not	NULL
involve	NULL
Bel-2	NULL
(	NULL
7a	NULL
)	NULL
.	NULL

We	NULL
would	NULL
postulate	NULL
that	NULL
in	NULL
vivo	NULL
the	NULL
biological	NULL
importance	NULL
of	NULL
LMP1-mediated	NULL
upregulation	NULL
of	NULL
Bcl-2	NULL
lies	NULL
in	NULL
its	NULL
ability	NULL
to	NULL
deliver	NULL
a	NULL
survival	NULL
signal	NULL
to	NULL
target	NULL
B	NULL
cells	NULL
and	NULL
thus	NULL
allow	NULL
persistence	NULL
of	NULL
the	NULL
virus	NULL
in	NULL
a	NULL
long-lived	NULL
B-cell	NULL
compartment	NULL
.	NULL

In	NULL
normal	NULL
lymphoid	NULL
follicles	NULL
,	NULL
the	NULL
resting	NULL
lymphocytes	NULL
are	NULL
Bel-2	NULL
positive	NULL
,	NULL
but	NULL
the	NULL
proliferating	NULL
Ki-67-positive	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
are	NULL
Bcel-2	NULL
negative	NULL
(	NULL
42	NULL
)	NULL
.	NULL

If	NULL
EBV	NULL
were	NULL
to	NULL
infect	NULL
Bcl-2-negative	NULL
B	NULL
cells	NULL
,	NULL
LMP1-mediated	NULL
upregulation	NULL
of	NULL
Bel-2	NULL
would	NULL
mimic	NULL
the	NULL
physiological	NULL
process	NULL
of	NULL
antigen-driven	NULL
selection	NULL
of	NULL
long-lived	NULL
B	NULL
cells	NULL
in	NULL
germinal	NULL
centers	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
.	NULL

If	NULL
EBV	NULL
were	NULL
to	NULL
infect	NULL
resting	NULL
B	NULL
cells	NULL
,	NULL
a	NULL
role	NULL
for	NULL
LMP1	NULL
in	NULL
regulating	NULL
Bcl-2	NULL
is	NULL
less	NULL
obvious	NULL
.	NULL

Indeed	NULL
,	NULL
because	NULL
resting	NULL
B	NULL
cells	NULL
already	NULL
express	NULL
a	NULL
high	NULL
level	NULL
of	NULL
Bel-2	NULL
,	NULL
which	NULL
is	NULL
only	NULL
slightly	NULL
elevated	NULL
following	NULL
infection	NULL
with	NULL
EBV	NULL
,	NULL
it	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
LMP1-mediated	NULL
upregulation	NULL
of	NULL
Bcl-2	NULL
is	NULL
of	NULL
little	NULL
relevance	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
35	NULL
)	NULL
.	NULL

However	NULL
,	NULL
this	NULL
interpretation	NULL
does	NULL
not	NULL
take	NULL
into	NULL
account	NULL
the	NULL
fact	NULL
that	NULL
mitogenic	NULL
activation	NULL
of	NULL
lymphocytes	NULL
in	NULL
vitro	NULL
results	NULL
in	NULL
decreased	NULL
Bel-2	NULL
protein	NULL
expression	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
50	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
human	NULL
immunodeficiency	NULL
virus-induced	NULL
loss	NULL
of	NULL
the	NULL
EBV	NULL
genome	NULL
in	NULL
LCLs	NULL
is	NULL
associated	NULL
with	NULL
downregulation	NULL
of	NULL
Bel-2	NULL
and	NULL
cell	NULL
death	NULL
(	NULL
9	NULL
)	NULL
.	NULL

It	NULL
therefore	NULL
seems	NULL
likely	NULL
that	NULL
EBV	NULL
,	NULL
through	NULL
expression	NULL
of	NULL
LMP1	NULL
,	NULL
specifically	NULL
VoL	NULL
.	NULL

68	NULL
,	NULL
1994	NULL
maintains	NULL
high	NULL
levels	NULL
of	NULL
Bel-2	NULL
in	NULL
activated	NULL
cells	NULL
that	NULL
would	NULL
otherwise	NULL
downregulate	NULL
the	NULL
cellular	NULL
oncogene	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
This	NULL
work	NULL
was	NULL
funded	NULL
by	NULL
the	NULL
Wellcome	NULL
Trust	NULL
and	NULL
by	NULL
the	NULL
Cancer	NULL
Research	NULL
Campaign	NULL
,	NULL
London	NULL
.	NULL

M.P.-P.	NULL
and	NULL
E.L.	NULL
were	NULL
supported	NULL
by	NULL
the	NULL
Swedish	NULL
Cancer	NULL
Society	NULL
and	NULL
Sveska	NULL
Sillskapet	NULL
for	NULL
Medicinsk	NULL
Forskn-	NULL
ing	NULL
.	NULL

We	NULL
are	NULL
indebted	NULL
to	NULL
Fernando	NULL
Arenzana-Seisdedos	NULL
(	NULL
Institut	NULL
Pasteur	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
for	NULL
providing	NULL
the	NULL
kB.CONA.LUC	NULL
reporter	NULL
plasmid	NULL
and	NULL
to	NULL
Jeff	NULL
Sample	NULL
(	NULL
St.	NULL
Jude	NULL
Children	NULL
's	NULL
Research	NULL
Hospital	NULL
,	NULL
Memphis	NULL
,	NULL
Tenn.	NULL
)	NULL
for	NULL
the	NULL
pCMV.LTR.GH	NULL
plasmid	NULL
.	NULL

Excellent	NULL
technical	NULL
assistance	NULL
was	NULL
provided	NULL
by	NULL
J.	NULL
Skinner	NULL
and	NULL
S.	NULL
Williams	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

REFERENCES	NULL
.	NULL

Aiello	NULL
,	NULL
A.	NULL
,	NULL
D.	NULL
Delia	NULL
,	NULL
M.	NULL
G.	NULL
Borrelio	NULL
,	NULL
D.	NULL
Biassoni	NULL
,	NULL
R.	NULL
Giardini	NULL
,	NULL
E.	NULL
Fontanella	NULL
,	NULL
F.	NULL
Pezzella	NULL
,	NULL
K.	NULL
Pulford	NULL
,	NULL
M.	NULL
Pierotti	NULL
,	NULL
and	NULL
G.	NULL
Della-Porta	NULL
.	NULL

1992	NULL
.	NULL

Flow	NULL
cytometric	NULL
detection	NULL
of	NULL
the	NULL
mitochondrial	NULL
Bel-2	NULL
protein	NULL
in	NULL
normal	NULL
and	NULL
neoplastic	NULL
human	NULL
lymphoid	NULL
cells	NULL
.	NULL

Cytometry	NULL
13:502-509.	NULL
.	NULL

Akbar	NULL
,	NULL
A.	NULL
N.	NULL
,	NULL
N.	NULL
Borthwick	NULL
,	NULL
M.	NULL
Salmon	NULL
,	NULL
W.	NULL
Gombert	NULL
,	NULL
M.	NULL
Bofill	NULL
,	NULL
N.	NULL
Shamsadeen	NULL
,	NULL
D.	NULL
Pilling	NULL
,	NULL
S.	NULL
Pett	NULL
,	NULL
J.	NULL
E.	NULL
Grundy	NULL
,	NULL
and	NULL
G.	NULL
Janossy	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
significance	NULL
of	NULL
low	NULL
Bel-2	NULL
expression	NULL
by	NULL
CD45RO	NULL
T	NULL
cells	NULL
in	NULL
normal	NULL
individuals	NULL
and	NULL
patients	NULL
with	NULL
acute	NULL
viral	NULL
infections	NULL
.	NULL

The	NULL
role	NULL
of	NULL
apoptosis	NULL
in	NULL
T	NULL
cell	NULL
memory	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:427-438.	NULL
.	NULL

Arenzana-Seisdedos	NULL
,	NULL
F.	NULL
,	NULL
B.	NULL
Fernandez	NULL
,	NULL
I.	NULL
Dominguez	NULL
,	NULL
J.	NULL
M.	NULL
Jacqué	NULL
,	NULL
D.	NULL
Thomas	NULL
,	NULL
M.	NULL
T.	NULL
Diaz-Meco	NULL
,	NULL
J.	NULL
Moscat	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Virelizier	NULL
.	NULL

1993	NULL
.	NULL

Phosphatidylcholine	NULL
hydrolysis	NULL
activates	NULL
NF-kB	NULL
and	NULL
increases	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
replication	NULL
in	NULL
human	NULL
monocytes	NULL
and	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:6596-6604.	NULL
.	NULL

Baichwal	NULL
,	NULL
V.	NULL
R.	NULL
,	NULL
and	NULL
B.	NULL
Sugden	NULL
.	NULL

1988	NULL
.	NULL

Transformation	NULL
of	NULL
Balb	NULL
3T3	NULL
cells	NULL
by	NULL
the	NULL
BNLF-1	NULL
gene	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
.	NULL

Oncogene	NULL
2:461-467.	NULL
.	NULL

Brattsand	NULL
,	NULL
G.	NULL
,	NULL
D.	NULL
A.	NULL
Cantrell	NULL
,	NULL
S.	NULL
Ward	NULL
,	NULL
F.	NULL
Ivars	NULL
,	NULL
and	NULL
M.	NULL
Gulberg	NULL
.	NULL

1990	NULL
.	NULL

Signal	NULL
transduction	NULL
through	NULL
the	NULL
T-cell	NULL
receptor-CD3	NULL
com-plex	NULL
:	NULL
evidence	NULL
for	NULL
heterogeneity	NULL
in	NULL
receptor	NULL
coupling	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

144:3651-3658.	NULL
.	NULL

Cohen	NULL
,	NULL
J.	NULL
I.	NULL
,	NULL
F.	NULL
Wang	NULL
,	NULL
and	NULL
E.	NULL
Kief	NULL
.	NULL

1991	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
nuclear	NULL
protein	NULL
2	NULL
mutations	NULL
define	NULL
essential	NULL
domains	NULL
for	NULL
transformation	NULL
and	NULL
transactivation	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:2545-2554.	NULL
.	NULL

Cornelius	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
J.	NULL
T.	NULL
Taylor	NULL
,	NULL
K.	NULL
Degitz	NULL
,	NULL
L.-J	NULL
.	NULL

Li	NULL
,	NULL
T.	NULL
J.	NULL
Lawley	NULL
,	NULL
and	NULL
S.	NULL
W.	NULL
Caughman	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
5	NULL
'	NULL
portion	NULL
of	NULL
the	NULL
ICAM-1	NULL
gene	NULL
confers	NULL
tissue-specific	NULL
differential	NULL
expression	NULL
levels	NULL
and	NULL
cytokine	NULL
respon-siveness	NULL
.	NULL

J	NULL
.	NULL

Invest	NULL
.	NULL

Dermatol	NULL
.	NULL

100:753-758.	NULL
a.Dawson	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
L.	NULL
Young	NULL
.	NULL

Personal	NULL
communication	NULL
.	NULL

.	NULL

Dawson	NULL
,	NULL
C.	NULL
W.	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Rickinson	NULL
,	NULL
and	NULL
L.	NULL
S.	NULL
Young	NULL
.	NULL

1990	NULL
.	NULL

Epstein	NULL
Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
inhibits	NULL
human	NULL
epithelial	NULL
cell	NULL
differentiation	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
344:777-780.	NULL
.	NULL

De	NULL
Rossi	NULL
,	NULL
A.	NULL
,	NULL
L.	NULL
Ometto	NULL
,	NULL
S.	NULL
Roncella	NULL
,	NULL
E.	NULL
D'Andrea	NULL
,	NULL
C.	NULL
Menin	NULL
,	NULL
F.	NULL
Calderazzo	NULL
,	NULL
M.	NULL
Rowe	NULL
,	NULL
M.	NULL
Ferrarini	NULL
,	NULL
and	NULL
L.	NULL
Chieco-Bianchi	NULL
.	NULL

1994	NULL
.	NULL

HIV-1	NULL
induces	NULL
down-regulation	NULL
of	NULL
bel-2	NULL
expression	NULL
and	NULL
death	NULL
by	NULL
apoptosis	NULL
of	NULL
EBV-immortalized	NULL
B	NULL
cells	NULL
:	NULL
a	NULL
model	NULL
for	NULL
a	NULL
persistent	NULL
``	NULL
self-limiting	NULL
``	NULL
HIV-1	NULL
infection	NULL
.	NULL

Virology	NULL
198:234-244.	NULL
.	NULL

de	NULL
Wet	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
K.	NULL
V.	NULL
Wood	NULL
,	NULL
M.	NULL
DeLuca	NULL
,	NULL
D.	NULL
R.	NULL
Helinski	NULL
,	NULL
and	NULL
S.	NULL
Subramani	NULL
.	NULL

1987	NULL
.	NULL

Firefly	NULL
luciferase	NULL
gene	NULL
:	NULL
structure	NULL
and	NULL
expression	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7:725-737	NULL
.	NULL

Fahraeus	NULL
,	NULL
R.	NULL
,	NULL
L.	NULL
Rymo	NULL
,	NULL
J.	NULL
S.	NULL
Rhim	NULL
,	NULL
and	NULL
G.	NULL
Klein	NULL
.	NULL

1990	NULL
.	NULL

Morphological	NULL
transformation	NULL
of	NULL
human	NULL
keratinocytes	NULL
expressing	NULL
the	NULL
LMP	NULL
gene	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
345:447-449	NULL
.	NULL

Fennewald	NULL
,	NULL
S.	NULL
,	NULL
V.	NULL
van	NULL
Santen	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1984	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
of	NULL
an	NULL
mRNA	NULL
transcribed	NULL
in	NULL
latent	NULL
growth-transforming	NULL
virus	NULL
indicates	NULL
that	NULL
it	NULL
may	NULL
encode	NULL
a	NULL
membrane	NULL
protein	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

51:411-419.	NULL
.	NULL

Finke	NULL
,	NULL
J.	NULL
,	NULL
R.	NULL
Fritzen	NULL
,	NULL
P.	NULL
Trivedi	NULL
,	NULL
K.	NULL
J.	NULL
Bross	NULL
,	NULL
W.	NULL
Lange	NULL
,	NULL
R.	NULL
Mertelsmann	NULL
,	NULL
and	NULL
G.	NULL
Dolken	NULL
.	NULL

1992	NULL
.	NULL

Expression	NULL
of	NULL
bel-2	NULL
in	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
lines	NULL
:	NULL
induction	NULL
by	NULL
latent	NULL
Epstein-Barr	NULL
virus	NULL
genes	NULL
.	NULL

Blood	NULL
80:459-469.	NULL
.	NULL

Gratama	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
M.	NULL
A.	NULL
P.	NULL
Oosterveer	NULL
,	NULL
F.	NULL
E.	NULL
Zwaan	NULL
,	NULL
J.	NULL
Lepoutre	NULL
,	NULL
G.	NULL
Klein	NULL
,	NULL
and	NULL
I.	NULL
Ernberg	NULL
.	NULL

1988	NULL
.	NULL

Eradication	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
by	NULL
allogeneic	NULL
bone	NULL
marrow	NULL
transplantation	NULL
:	NULL
implications	NULL
for	NULL
sites	NULL
of	NULL
viral	NULL
latency	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:8693-8696.	NULL
.	NULL

Gregory	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
C.	NULL
Dive	NULL
,	NULL
S.	NULL
Henderson	NULL
,	NULL
C.	NULL
Smith	NULL
,	NULL
G.	NULL
T.	NULL
Williams	NULL
,	NULL
20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31.	NULL
ta	NULL
to	NULL
34	NULL
.	NULL

INDUCTION	NULL
OF	NULL
Bel-2	NULL
BY	NULL
LMP	NULL
}	NULL
5611	NULL
J.	NULL
Gordon	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Rickinson	NULL
.	NULL

1991	NULL
.	NULL

Activation	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
genes	NULL
protects	NULL
human	NULL
B	NULL
cells	NULL
from	NULL
death	NULL
by	NULL
apoptosis	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
349:612-614.	NULL
.	NULL

Gregory	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
M.	NULL
Rowe	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Rickinson	NULL
.	NULL

1990	NULL
.	NULL

Different	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
-B	NULL
cell	NULL
interactions	NULL
in	NULL
phenotypically	NULL
distinct	NULL
clones	NULL
of	NULL
a	NULL
Burkitt	NULL
lymphoma	NULL
cell	NULL
line	NULL
.	NULL

J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

71:1481-1495.	NULL
.	NULL

Grilli	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
S.	NULL
Chiu	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Lenardo	NULL
.	NULL

1993	NULL
.	NULL

NF-kB	NULL
and	NULL
Rel-participants	NULL
in	NULL
a	NULL
multiform	NULL
transcriptional	NULL
regulatory	NULL
sys-tem	NULL
.	NULL

Int	NULL
.	NULL

Rev	NULL
.	NULL

Cytol	NULL
.	NULL

143:1-62.	NULL
.	NULL

Hammarskjold	NULL
,	NULL
M.-L.	NULL
,	NULL
and	NULL
M.	NULL
C.	NULL
Simurda	NULL
.	NULL

1992	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
transactivates	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
through	NULL
induction	NULL
of	NULL
NF-kB	NULL
activity	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:6496-6501.	NULL
.	NULL

Hammerschmidt	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
B.	NULL
Sugden	NULL
.	NULL

1989	NULL
.	NULL

Genetic	NULL
analysis	NULL
of	NULL
immortalizing	NULL
functions	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
in	NULL
human	NULL
B	NULL
lymphocytes	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
340:393-397	NULL
.	NULL

Henderson	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Rowe	NULL
,	NULL
C.	NULL
Gregory	NULL
,	NULL
F.	NULL
Wang	NULL
,	NULL
E.	NULL
Kieff	NULL
,	NULL
and	NULL
A.	NULL
Rickinson	NULL
.	NULL

1991	NULL
.	NULL

Induction	NULL
of	NULL
be/-2	NULL
expression	NULL
by	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein-1	NULL
protects	NULL
infected	NULL
B	NULL
cells	NULL
from	NULL
programmed	NULL
cell	NULL
death	NULL
.	NULL

Cell	NULL
65:1107-1115	NULL
.	NULL

Himes	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
L.	NULL
S.	NULL
Coles	NULL
,	NULL
R.	NULL
Katsikeros	NULL
,	NULL
R.	NULL
K.	NULL
Lang	NULL
,	NULL
and	NULL
M.	NULL
F.	NULL
Shannon	NULL
.	NULL

1993	NULL
.	NULL

HTLV-1	NULL
tax	NULL
activation	NULL
of	NULL
the	NULL
GM-CSF	NULL
and	NULL
G-CSF	NULL
promoters	NULL
requires	NULL
the	NULL
interaction	NULL
of	NULL
NF-kB	NULL
with	NULL
other	NULL
transcription	NULL
factor	NULL
families	NULL
.	NULL

Oncogene	NULL
8:3189-3197	NULL
.	NULL

Hockenbury	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
M.	NULL
Zutter	NULL
,	NULL
W.	NULL
Hicky	NULL
,	NULL
M.	NULL
Nahm	NULL
,	NULL
and	NULL
S.	NULL
J.	NULL
Korsmeyer	NULL
.	NULL

1991	NULL
.	NULL

BCL2	NULL
protein	NULL
is	NULL
topographically	NULL
restricted	NULL
in	NULL
tissues	NULL
characterized	NULL
by	NULL
apoptotic	NULL
cell	NULL
death	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:6961-6965.	NULL
.	NULL

Johnson	NULL
,	NULL
G.	NULL
,	NULL
R.	NULL
S.	NULL
Davidson	NULL
,	NULL
K.	NULL
C.	NULL
McNamee	NULL
,	NULL
G.	NULL
Russell	NULL
,	NULL
D.	NULL
Goodwin	NULL
,	NULL
and	NULL
E.	NULL
J.	NULL
Holborrow	NULL
.	NULL

1982	NULL
.	NULL

Fading	NULL
of	NULL
immunofluorescence	NULL
during	NULL
microscopy	NULL
:	NULL
a	NULL
study	NULL
of	NULL
this	NULL
phenomenon	NULL
and	NULL
its	NULL
remedy	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
55:231-242	NULL
.	NULL

24	NULL
.	NULL

Kaye	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
K.	NULL
M.	NULL
Izumi	NULL
,	NULL
and	NULL
E.	NULL
Kief	NULL
.	NULL

1993	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
is	NULL
essential	NULL
for	NULL
B-lymphocyte	NULL
growth	NULL
transformation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:9150-9154	NULL
.	NULL

Kief	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
D.	NULL
Leibowitz	NULL
.	NULL

1990	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
and	NULL
its	NULL
replication	NULL
,	NULL
p.	NULL
1889-1920	NULL
.	NULL

In	NULL
B.	NULL
N.	NULL
Fields	NULL
and	NULL
D.	NULL
M.	NULL
Knipe	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Fields	NULL
virology	NULL
,	NULL
2nd	NULL
ed	NULL
.	NULL

Raven	NULL
Press	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Laherty	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
H.	NULL
M.	NULL
Hu	NULL
,	NULL
A.	NULL
W.	NULL
Opipari	NULL
,	NULL
F.	NULL
Wang	NULL
,	NULL
and	NULL
V.	NULL
M.	NULL
Dixit	NULL
.	NULL

1992	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
LMP1	NULL
gene	NULL
product	NULL
induces	NULL
A20	NULL
zinc	NULL
finger	NULL
protein	NULL
expression	NULL
by	NULL
activating	NULL
nuclear	NULL
factor	NULL
kB	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:24157-24160	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
:	NULL
a	NULL
pleiotropic	NULL
mediator	NULL
of	NULL
inducible	NULL
and	NULL
tissue-specific	NULL
gene	NULL
control	NULL
.	NULL

Cell	NULL
58	NULL
:	NULL
227-229	NULL
.	NULL

Liebowitz	NULL
,	NULL
D.	NULL
,	NULL
D.	NULL
Wang	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1986	NULL
.	NULL

Orientation	NULL
and	NULL
patching	NULL
of	NULL
the	NULL
latent	NULL
infection	NULL
membrane	NULL
protein	NULL
encoded	NULL
by	NULL
Epstein-Barr	NULL
virus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

58:233-237	NULL
.	NULL

Liu	NULL
,	NULL
Y.-J	NULL
.	NULL

,	NULL
D.	NULL
E.	NULL
Joshua	NULL
,	NULL
G.	NULL
T.	NULL
Williams	NULL
,	NULL
C.	NULL
A.	NULL
Smith	NULL
,	NULL
J.	NULL
Gordon	NULL
,	NULL
and	NULL
I.	NULL
C.	NULL
MacLennan	NULL
.	NULL

1989	NULL
.	NULL

Mechanism	NULL
of	NULL
antigen-driven	NULL
selection	NULL
in	NULL
germinal	NULL
centres	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
342:929-931	NULL
.	NULL

Liu	NULL
,	NULL
Y.-J	NULL
.	NULL

,	NULL
D.	NULL
Y.	NULL
Mason	NULL
,	NULL
G.	NULL
D.	NULL
Johnson	NULL
,	NULL
S.	NULL
Abbot	NULL
,	NULL
C.	NULL
D.	NULL
Gregory	NULL
,	NULL
D.	NULL
L.	NULL
Hardie	NULL
,	NULL
J.	NULL
Gordon	NULL
,	NULL
and	NULL
I.	NULL
C.	NULL
M.	NULL
MacLennan	NULL
.	NULL

1991	NULL
.	NULL

Germinal	NULL
center	NULL
cells	NULL
express	NULL
Bel-2	NULL
protein	NULL
after	NULL
activation	NULL
by	NULL
signals	NULL
which	NULL
prevent	NULL
entry	NULL
to	NULL
apoptosis	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

21:1905-1910	NULL
.	NULL

Lozzio	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
and	NULL
B	NULL
.	NULL

B.	NULL
Lozzio	NULL
.	NULL

1975	NULL
.	NULL

Human	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
cell	NULL
line	NULL
with	NULL
positive	NULL
Philadelphia	NULL
chromosome	NULL
.	NULL

Blood	NULL
45:32	NULL
1-334.	NULL
.	NULL

Mann	NULL
,	NULL
K.	NULL
P.	NULL
,	NULL
D.	NULL
Staunton	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Thorley-Lawson	NULL
.	NULL

1985	NULL
.	NULL

Epstein-Barr	NULL
virus-encoded	NULL
protein	NULL
found	NULL
in	NULL
plasma	NULL
membranes	NULL
of	NULL
transformed	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

55:710-720.	NULL
.	NULL

Martin	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
B.	NULL
Sugden	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
latent	NULL
membrane	NULL
protein	NULL
oncoprotein	NULL
resembles	NULL
growth	NULL
factor	NULL
receptors	NULL
in	NULL
the	NULL
properties	NULL
of	NULL
its	NULL
turnover	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
.	NULL

2:653-660	NULL
.	NULL

Martin	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
B.	NULL
Sugden	NULL
.	NULL

1991	NULL
.	NULL

Transformation	NULL
by	NULL
the	NULL
oncogenic	NULL
latent	NULL
membrane	NULL
protein	NULL
correlates	NULL
with	NULL
its	NULL
rapid	NULL
turnover	NULL
,	NULL
membrane	NULL
localization	NULL
,	NULL
and	NULL
cytoskeletal	NULL
association	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:3246-3258.	NULL
.	NULL

Martin	NULL
,	NULL
J.	NULL
,	NULL
D.	NULL
Veis	NULL
,	NULL
S.	NULL
J.	NULL
Korsmeyer	NULL
,	NULL
and	NULL
B.	NULL
Sugden	NULL
,	NULL
1993	NULL
.	NULL

Latent	NULL
membrane	NULL
protein	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
induces	NULL
cellular	NULL
pheno-types	NULL
independently	NULL
of	NULL
expression	NULL
of	NULL
Bel-2	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:5269-5278.	NULL
.	NULL

Masucci	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
B.	NULL
Contreras-Salazar	NULL
,	NULL
E.	NULL
Ragnar	NULL
,	NULL
K.	NULL
Falk	NULL
,	NULL
J	NULL
.	NULL

5612	NULL
37	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

44	NULL
.	NULL

44a	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

ROWE	NULL
ET	NULL
AL	NULL
Minarovits	NULL
,	NULL
I.	NULL
Ernberg	NULL
,	NULL
and	NULL
G.	NULL
Klein	NULL
.	NULL

1989	NULL
.	NULL

5-Azacytidine	NULL
upregulates	NULL
the	NULL
expression	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
nuclear	NULL
antigen	NULL
2	NULL
(	NULL
EBNA-2	NULL
)	NULL
through	NULL
EBNA-6	NULL
and	NULL
latent	NULL
membrane	NULL
protein	NULL
in	NULL
the	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
line	NULL
Rael	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:3135-3141	NULL
.	NULL

Miller	NULL
,	NULL
G.	NULL
1990	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
.	NULL

Biology	NULL
,	NULL
pathogenesis	NULL
,	NULL
and	NULL
medical	NULL
aspects	NULL
,	NULL
p.	NULL
1921-1958	NULL
.	NULL

In	NULL
B.	NULL
N.	NULL
Fields	NULL
and	NULL
D.	NULL
M.	NULL
Knipe	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Fields	NULL
virology	NULL
,	NULL
2nd	NULL
ed	NULL
.	NULL

Raven	NULL
Press	NULL
,	NULL
New	NULL
York	NULL
.	NULL

.	NULL

Nunez	NULL
,	NULL
G.	NULL
,	NULL
L.	NULL
London	NULL
,	NULL
D.	NULL
Hockenberry	NULL
,	NULL
M.	NULL
Alexander	NULL
,	NULL
J.	NULL
P.	NULL
McKearn	NULL
,	NULL
and	NULL
S.	NULL
J.	NULL
Korsmeyer	NULL
.	NULL

1990	NULL
.	NULL

Deregulated	NULL
BCL-2	NULL
gene	NULL
expression	NULL
selectively	NULL
prolongs	NULL
survival	NULL
of	NULL
growth	NULL
factor-deprived	NULL
hemopoietic	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

144:3602-3610.	NULL
.	NULL

Peng	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
E.	NULL
Lundgren	NULL
.	NULL

1992	NULL
.	NULL

Transient	NULL
expression	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
LMP1	NULL
gene	NULL
in	NULL
human	NULL
primary	NULL
B	NULL
cells	NULL
induces	NULL
cellular	NULL
activation	NULL
and	NULL
DNA	NULL
synthesis	NULL
.	NULL

Oncogene	NULL
7:1775-1782	NULL
.	NULL

Peng	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
E.	NULL
Lundgren	NULL
.	NULL

1993	NULL
.	NULL

Transient	NULL
expression	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
LMPI	NULL
gene	NULL
in	NULL
B-cell	NULL
chronic	NULL
lymphocytic	NULL
leukemia	NULL
cells	NULL
,	NULL
T-cells	NULL
and	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
:	NULL
cell-type-independent-induction	NULL
of	NULL
CD23	NULL
,	NULL
CD21	NULL
,	NULL
and	NULL
ICAM-1	NULL
.	NULL

Leukemia	NULL
1993:104-112	NULL
.	NULL

Perkins	NULL
,	NULL
N.	NULL
D.	NULL
,	NULL
R.	NULL
M.	NULL
Schmid	NULL
,	NULL
C.	NULL
S.	NULL
Duckett	NULL
,	NULL
K.	NULL
Leung	NULL
,	NULL
and	NULL
N.	NULL
R.	NULL
Rice	NULL
.	NULL

1992	NULL
.	NULL

Distinct	NULL
combinations	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
determine	NULL
the	NULL
specificity	NULL
of	NULL
transcriptional	NULL
activation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:1529-1533	NULL
.	NULL

Pezzella	NULL
,	NULL
F.	NULL
,	NULL
A.	NULL
Tse	NULL
,	NULL
J.	NULL
L.	NULL
Cordell	NULL
,	NULL
K.	NULL
A.	NULL
F.	NULL
Pulford	NULL
,	NULL
K.	NULL
C.	NULL
Gatter	NULL
,	NULL
and	NULL
D.	NULL
Y.	NULL
Mason	NULL
.	NULL

1990	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
be/-2	NULL
oncogene	NULL
protein	NULL
is	NULL
not	NULL
specific	NULL
for	NULL
the	NULL
14:18	NULL
chromosomal	NULL
translocation	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

137:225-232.	NULL
.	NULL

Rice	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
and	NULL
M.	NULL
K.	NULL
Ernst	NULL
,	NULL
1993	NULL
.	NULL

In	NULL
vivo	NULL
control	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
IxBa	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:4685-4695	NULL
.	NULL

Rothlein	NULL
,	NULL
R.	NULL
,	NULL
M.	NULL
Dustin	NULL
,	NULL
S.	NULL
D.	NULL
Marlin	NULL
,	NULL
and	NULL
T.	NULL
A.	NULL
Springer	NULL
.	NULL

1986	NULL
.	NULL

A	NULL
human	NULL
intercellular	NULL
adhesion	NULL
molecule	NULL
(	NULL
ICAM-1	NULL
)	NULL
distinct	NULL
from	NULL
LFA-1	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

137:1270-1274	NULL
.	NULL

Rowe	NULL
,	NULL
M.	NULL
Unpublished	NULL
data	NULL
.	NULL

Rowe	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
S.	NULL
Evans	NULL
,	NULL
L.	NULL
S.	NULL
Young	NULL
,	NULL
K.	NULL
Hennessy	NULL
,	NULL
E.	NULL
Kieff	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Rickinson	NULL
.	NULL

1987	NULL
.	NULL

Monoclonal	NULL
antibodies	NULL
to	NULL
the	NULL
latent	NULL
membrane	NULL
protein	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
reveal	NULL
heterogeneity	NULL
of	NULL
the	NULL
protein	NULL
and	NULL
inducible	NULL
expression	NULL
in	NULL
virus-transformed	NULL
cells	NULL
.	NULL

J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

68:1575-1586	NULL
.	NULL

Rowe	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
L.	NULL
Lear	NULL
,	NULL
D.	NULL
Croom-Carter	NULL
,	NULL
A.	NULL
H.	NULL
Davies	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Rickinson	NULL
.	NULL

1992	NULL
.	NULL

Three	NULL
pathways	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
gene	NULL
activation	NULL
from	NULL
EBNAI-positive	NULL
latency	NULL
in	NULL
B	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:122-131	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

J.	NULL
Viror..	NULL
Rowe	NULL
,	NULL
M.	NULL
,	NULL
C.	NULL
M.	NULL
Rooney	NULL
,	NULL
C.	NULL
F.	NULL
Edwards	NULL
,	NULL
G.	NULL
M.	NULL
Lenoir	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Rickinson	NULL
.	NULL

1986	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
status	NULL
and	NULL
tumour	NULL
cell	NULL
phenotype	NULL
in	NULL
sporadic	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
37:367-373	NULL
.	NULL

Rowe	NULL
,	NULL
M.	NULL
,	NULL
D.	NULL
T.	NULL
Rowe	NULL
,	NULL
C.	NULL
D.	NULL
Gregory	NULL
,	NULL
L.	NULL
S.	NULL
Young	NULL
,	NULL
P.	NULL
J.	NULL
Farrell	NULL
,	NULL
H.	NULL
Rupani	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Rickinson	NULL
.	NULL

1987	NULL
.	NULL

Differences	NULL
in	NULL
B	NULL
cell	NULL
growth	NULL
phenotype	NULL
reflect	NULL
novel	NULL
patterns	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
gene	NULL
expression	NULL
in	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

6:2743-2751	NULL
.	NULL

Sanchez-Madrid	NULL
,	NULL
F.	NULL
,	NULL
A.	NULL
M.	NULL
Krensky	NULL
,	NULL
C.	NULL
F.	NULL
Ware	NULL
,	NULL
E.	NULL
Robbins	NULL
,	NULL
J.	NULL
L.	NULL
Strominger	NULL
,	NULL
S.	NULL
J.	NULL
Burakoff	NULL
,	NULL
and	NULL
T.	NULL
A.	NULL
Springer	NULL
.	NULL

1982	NULL
.	NULL

Three	NULL
distinct	NULL
antigens	NULL
associated	NULL
with	NULL
human	NULL
T-lymphocyte-mediated	NULL
cytolysis	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
,	NULL
.	NULL

USA	NULL
79:7489-7493	NULL
.	NULL

Schena	NULL
,	NULL
M.	NULL
,	NULL
L.-G.	NULL
Larsson	NULL
,	NULL
D.	NULL
Gottardi	NULL
,	NULL
G.	NULL
Gaidano	NULL
,	NULL
M.	NULL
Carlsson	NULL
,	NULL
K.	NULL
Nilsson	NULL
,	NULL
and	NULL
F.	NULL
Caligaris-Cappio	NULL
.	NULL

1992	NULL
.	NULL

Growth-	NULL
and	NULL
differen-tiation-associated	NULL
expression	NULL
of	NULL
be/-2	NULL
in	NULL
B-chronic	NULL
lymphocytic	NULL
leukemia	NULL
cells	NULL
.	NULL

Blood	NULL
79:2981-2989.	NULL
.	NULL

Tomkinson	NULL
,	NULL
B.	NULL
,	NULL
E.	NULL
Robertson	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1993	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
nuclear	NULL
proteins	NULL
EBNA-3A	NULL
and	NULL
EBNA-3C	NULL
are	NULL
essential	NULL
for	NULL
B-lymphocyte	NULL
growth	NULL
transformation	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:2014-2025.	NULL
.	NULL

Voraberger	NULL
,	NULL
G.	NULL
,	NULL
R.	NULL
Schifer	NULL
,	NULL
and	NULL
C.	NULL
Stratowa	NULL
.	NULL

1991	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
human	NULL
gene	NULL
for	NULL
intracellular	NULL
adhesion	NULL
molecule	NULL
1	NULL
and	NULL
analysis	NULL
of	NULL
its	NULL
5'-regulatory	NULL
region	NULL
.	NULL

Induction	NULL
by	NULL
cytokines	NULL
and	NULL
phorbol	NULL
ester	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

147:2777-2786.	NULL
.	NULL

Wang	NULL
,	NULL
D.	NULL
,	NULL
D.	NULL
Liebowitz	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1985	NULL
.	NULL

An	NULL
EBV	NULL
membrane	NULL
protein	NULL
expressed	NULL
in	NULL
immortalized	NULL
lymphocytes	NULL
transforms	NULL
established	NULL
rodent	NULL
cells	NULL
.	NULL

Cell	NULL
43:831-840.	NULL
.	NULL

Wang	NULL
,	NULL
D.	NULL
,	NULL
D.	NULL
Liebowitz	NULL
,	NULL
F.	NULL
Wang	NULL
,	NULL
C.	NULL
Gregory	NULL
,	NULL
A.	NULL
Rickinson	NULL
,	NULL
R.	NULL
Larson	NULL
,	NULL
T.	NULL
Springer	NULL
,	NULL
and	NULL
E.	NULL
Kief	NULL
,	NULL
1988	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
latent	NULL
infection	NULL
membrane	NULL
protein	NULL
alters	NULL
the	NULL
human	NULL
B-lymphocyte	NULL
phe-notype	NULL
:	NULL
deletion	NULL
of	NULL
the	NULL
amino	NULL
terminus	NULL
abolishes	NULL
activity	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

62:4173-4184.	NULL
.	NULL

Wang	NULL
,	NULL
F.	NULL
,	NULL
C.	NULL
Gregory	NULL
,	NULL
C.	NULL
Sample	NULL
,	NULL
M.	NULL
Rowe	NULL
,	NULL
D.	NULL
Liebowitz	NULL
,	NULL
R.	NULL
Murray	NULL
,	NULL
A.	NULL
Rickinson	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1990	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
(	NULL
LMP1	NULL
)	NULL
and	NULL
nuclear	NULL
proteins	NULL
2	NULL
and	NULL
3C	NULL
are	NULL
effectors	NULL
of	NULL
phenotypic	NULL
changes	NULL
in	NULL
B	NULL
lymphocytes	NULL
:	NULL
EBNA-2	NULL
and	NULL
LMP1	NULL
cooperatively	NULL
induce	NULL
CD23	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:2309-2318.	NULL
.	NULL

Yao	NULL
,	NULL
Q.	NULL
Y.	NULL
,	NULL
P.	NULL
Ogan	NULL
,	NULL
M.	NULL
Rowe	NULL
,	NULL
M.	NULL
Wood	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Rickinson	NULL
.	NULL

1989	NULL
.	NULL

Epstein-Barr	NULL
virus-infected	NULL
B	NULL
cells	NULL
persist	NULL
in	NULL
the	NULL
circulation	NULL
of	NULL
acyclovir-treated	NULL
virus-carriers	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
43:67-71.	NULL
.	NULL

Young	NULL
,	NULL
L.	NULL
S.	NULL
,	NULL
and	NULL
M.	NULL
Rowe	NULL
.	NULL

1992	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
,	NULL
lymphomas	NULL
and	NULL
Hodgkin	NULL
's	NULL
disease	NULL
.	NULL

Semin	NULL
.	NULL

Cancer	NULL
Biol	NULL
.	NULL

3:273-284	NULL
.	NULL

